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Abstract 
The P300 component of the auditory EEG event-related 
potential (ERP) and Positron Emission Tomography (PET) 
were investigated in individuals considered to be early 
cases of probable Alzheimer's type dementia (PAD) and a 
control group of similar age. Two questions were 
investigated: (a) The degree to which P300 latency was 
sensitive to neurocognitive changes in very early stages 
of PAD; and (b) The relationship between P300 latency and 
specific areas of reduced neural functions as reflected in 
PET scans. A significant difference was found between PAD 
and normal subjects in P300 latencies, with those in the 
patient group having longer P300 latencies than the 
control group. The P300 latencies were significantly 
correlated with cortical, but not subcortical, metabolic 
rates. The highest correlation was between P300 latency 
and pareital PET scores, with other significant 
correlations with P300 latency in the following order: 
frontal, temporal and parahippocampal. These data 
indicate that P300 latency is an index of the integrity of 
association cortex and, as such, is sensitive to the very 
early stages of Alzheimer's dementia. 
P300 and PET 
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Dementia of the Alzheimer's type (OAT) is diagnosed 
in at least one-half of all cases of dementia [19] but 
nevertheless remains a difficult diagnosis to make with 
confidence. This category of dementia is characterized by 
atrophy of the cerebral cortex and dilation of cerebral 
ventricles. This change in the cerebral anatomy, though 
often more marked, is not necessarily different than that 
of normal aging. Senile plaques and neurofibrillary 
tangles, which are believed to be partially responsible 
for the dementing process, are found in both demented and 
non-demented persons, although usually in different 
quantities. The nucleus basalis appears to be responsible 
for diffuse cholinergic projection to the cerebral cortex. 
Significant cell loss has been reported [8] in the nucleus 
basalis possibly acccounting for the cholinergice deficit 
found in Alzheiemr's patients. The dependence upon 
behavioral signs for the clinical diagnosis of OAT in the 
living patient often causes confusion between the various 
dementias, as well as between dementia and various other 
conditions which have overlapping behavioral features, 
such as depression. Both anatomical and neurobehavioral 
differences are obviously least distinct in very mild, 
early stages of OAT when diagnoses are usually sought. 
There is, th~s, a need for more precise and objective 
P300 and PET 
means of diagnosing Alzheimer~s dementia in the elderly. 
The latency of the P300 component of the auditory event-
related potential (ERP) has shown promise as a means of 
evaluating cognitive functioning. 
Marsh and Thompson [23] were perhaps the first to 
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report increases with normal adult aging in P300 latency 
measurements using auditory discriminative tasks. An 
increase in latency was seen for normal elderly 
individuals. A continuous linear or exponential increase in 
P300 latency with adult aging has been demonstrated by a 
number of investigators [5 ,17, 38]. 
The latency of the P300 increases further in most cases 
of persons with a neurological disease which results in 
dementia, whereas persons with functional disorders or 
neurological disease without cognitive impairment rarely 
exhibit an increase in P300 latency. [4, 17, 38]. Thus 
P300 latency measurements may prove to be an important 
tool in the differential diagnosis between demented and 
non-demented patients. 
One possible cause for the occurrence of a P300 
outside the normal range for some demented patients and 
not for others could be the sensitivity of the P300 
latency to cortical neural activity within specific 
regions of the brain. That is, regardless of the global 
level of dementia, certain specific neural tissue must be 
P300 and PET 
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dysfunctional for P300 latency to become abnormally long~ 
The neural substrates for abnormal P300 latencies are not 
known, that is, it is not as yet known whether or not the 
abnormally prolonged latencies seen in dementia are 
associated with functional deficits in specific brain 
systems, structures, or regions. 
With recent advances in Positron Emission Tomography 
(PET), it is now possible to measure the metabolic 
activity of specific brain regions in living, active 
patients. The earliest and most specific changes 
occurring in diseases of the brain hav~ been shown to be 
reflected in disturbances of underlying biochemical 
proce~ses [32]. 
PET scans have recently been found to be 
characteristically abnormal in cases of Alzheimer's 
disease. Kuhl et al. [20] found that 2-deoxy-2-fluror-D-
glucose (FDG) scans in Alzheimer's type dementia revealed 
abnormal metabolic patterns suggestive of neuronal 
degeneration which was most severe in the cortex. The 
average decrease in zonal metabolism was 47% in parietal 
and dorsolateral occipital cortex, and 28% in caudate and 
thalamus. There is ·a significant positive correlation 
between cortical glucose use measured by the PET and the 
Full Scale IQ, Verbal IQ and Performance IQ scores on the 
Wechsler Adult Intelligence Scale in both normal and 
P300 and PET 
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demented patients [7]. It has been found that cerebral 
glucose utilization is most dramatically reduced in the 
posterior pareital cortex of DAT patients [15]. Cerebral 
blood flow was also found to be markedly reduced in the 
pareital and temporal regions for these patients [16]. 
This study investigated the relationship between PET 
scan and P300 latency measures in individuals considered 
to be early, mild cases of probable Alzheimer's type 
dementia (PAD) in order to determine the relationship of 
P300 latency increase to specific regional changes in 
brain metabolism. I~ was hypothesized that: (a) P300 
latency is a reflection of brain integrity which will be 
manifested in PET indices of metabolic rate. (b) P300 
latency will reflect most strongly neocortex and/or 
archecortex metabolic rate and less metabolic activity of 
subcortical regions. (c) P300 latency will be relatively 
longer in patients with reduced parietal and/or temporal 
metabolic rate. 
Method 
Subject Evaluation 
A very large group of possible subjects was recruited 
from the community via letters sent to area physicians, 
neurologists and psychiatrists asking for referrals of 
normal controls and persons with early signs of memory and 
intellect problems. The research program was also 
P300 and PET 
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announced in local newspapers, trade journals and on radio 
and television interviews. 
Each potential subject was given an initial 
assessment to determine if s/he met standardized intake 
criteria of early dementia and to exclude those not 
meeting these criteria or alternatively, consider them for 
the control group. An interviewer gathered information 
regarding educational and occupational background, and 
medical or neurological history. Part of this information 
was obtained from a second source who knew the subject 
well. A brief standardized test of cognitive and 
functional abilities, the Mini-Mental state (MMS; Appendix 
F) [13], was completed. The significant other of the 
patient was asked to rate the patient (on a 7 point scale) 
in daily functions of remembering, problem solving, 
clinical signs, and home activities using the Dementia 
Scale [2] with inclusion criterion being a score of equal 
to or less than 10. The Zung Self Rating Depression Test 
was also given with a score of less than 60 excluding the 
patient from this study. A score between 2 and 6 on the 
partial Hachinski Ischemic Scale ·(Appendix G) was taken as 
a sign of possible dementia, a score of 7 or greater 
suggested possible multiple infarct dementia and excluded 
the patient. 
P300 and PET 
Following the initial assessment, a more thorough 
dementia evaluation was completed to establish a 
preliminary diagnosis. A full medical, psychiatric and 
social history was obtained. Further tests included 
complete neuropsychological and neurolinguistic 
evaluations. The degree of memory impairment was 
assessed, cognitive status was fully evaluated and the 
presence of aphasic or apraxic signs noted. In order to 
be included in the study each patient earned scores as 
follows: WAIS Digit Span (forward and backward) with a 
score equal to or less than 8, the Word Generation Test 
(less than 12 in 1 minute), and Rey's Visual Scanning 
Tests [36] (less than 18 words in one minute, i.e. the 
25th percentile) . 
The final stage of subject evaluation involved a 
series of medical laboratory tests to rule out sources of 
cognitive impairment other than DAT. Medical tests 
included: chest x-ray, electrocardiogram, urinalysis, 
erythrocyte sedimentation rate, full screening blood 
panel, B12, folate, and thyroid function tests. Tests to 
assess organic brain syndrome included EEG, MRI and CT 
Scans. 
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The control group consisted of 17 individuals 52-71 
years of age who agreed to participate as volunteers. All 
PJOO and PET 
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individuals in the control group earned a Mini-mental 
State score of 28-30 and fell within the normal range on a 
battery of neuropsychological tests. 
The patient group consisted of 32 individuals 56-76 
years of age with a score on the Mini-mental state between 
20-27. Their scores on the neuropsychological battery fell 
below the normal range, and they exhibited behavioral 
symptoms congruent with a diagnosis of mild dementia. 
Patients were divided into two subgroups according to 
Clinical Diagnostic Ratings (CDR; see Appendix E) [19] of 
0.5 and 1.0. This constitutes possible and probable OAT, 
respectively. The CDR utilzes information gathered 
through interviews to determine the stage of dementia a 
patient has reached. Six categories of functioning are 
assessed including: memory, orientation, judgment/problem 
solving, community affairs, home/hobbies and personal 
care. 
P300 Recordins 
For P300 recording, EEG electrodes were fixed with 
~lec~rolyte paste at the Fz, Cz, Pz sites on the patient's 
head (International 10-20 Electrode System). Ear clips 
were used for reference and ground. Subjects were seated 
in an electrically shielded, sound attenuating room for 
EEG recording, and headphones placed over the patient's 
P300 and PET 
ears. An attendant was in the recording room with the 
subject at all times. 
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An "auditory oddball" stimulus paradigm was utilized 
with frequent tones (250 Hz, 70db SPL, 60 msec duration) 
occurring on 80% of the trials and target tones (450 Hz, 
84db SPL, 60 msec duration) occurring on 20% of the 
trials. One tone was heard every 1.5 seconds until a 
total of 32 artifact free responses to the target tone 
were recorded. Responses spoiled by muscle or eye 
movement artifact were rejected automatically by the 
averaging computer according to an amplitude threshold 
adjusted for each individual subject. Each subject was 
asked to listen to the tones as they were presented and 
instructed to count silently the louder, higher pitch tone 
(target tone), and ignore the softer, lower pitch tone. 
The attendant informed the subject that periodically the 
tones would be stopped and a count asked for from the 
subject. Following these instructions, a short trial 
segment was presented in order ,to determine that the 
subject understood the instructions and was able to 
discriminate between the two tones and do the task. In 
the event that the . subject was unable to keep an internal 
count, s/he was instructed to lift her/his index finger at 
the sound of the target tone. If necessary, this skill 
was shaped during practice trials by the attendant, 
P300 and PET 
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indicating to the subject when to lift a finger. When it 
was determined that the subject was prepared for the task, 
two runs were completed with a short break in between 
runs. For this study, six patients were unable to keep 
an internal count, and the shaping technique was utilized. 
Each of these six patients had an initial CDR of 1.0 and a 
P300 z-score which exceeded 2 SD beyond the mean. 
For each recording locus, event-related potentials 
were amplified (Gain= 14,000, Bandpass= .1-50Hz), 
digitized (250 samples/sec) and separately averaged for 
the frequent and target stimuli. Average ERPs spanned 
1000 msec, including a 100 msec prestimulus epoch. 
Average responses were stored on computer disks and 
plotted on an X-Y plotter immediately following a run. 
For each electrode derivation, plots include the ERP to 
the frequent and target stimulus, and the difference 
between these potentials for reasons explained below. 
P300 latencies were measured at PZ, CZ, and FZ sites. 
The P300 component was identified as the first positive 
peak after 250 msec. Where a single peak does not appear, 
but rather a flat-top or multiple peak waveform, a midwave 
measurement was made. Scalp topography and difference 
waveforms (i.e. target minus frequent) were used as aids 
in identifying the P300 wave. 
P300 and PET 
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Since P300 latency in this paradigm increases 
progressively with normal aging [5], z-score deviation 
from the age/P300 latency function adjusted for this 
effect on the basis of a larger normative group. The P300 
latency measures at Cz were expressed in z-scores in 
reference to the age/P300 latency regression function 
derived from a very large group (N= 71, 57 < 40 years of 
age) of normal, elderly individuals previously recorded 
using the same task and recording procedures. 
PET Scan 
Each patient and control underwent a glucose 
utilization Positron Emission Tomography (PET) scan which 
involved the injection of F-18 labeled 2-deoxy-2-fluror-0-
glucose (FOG). An extension of Sokoloff's OG model for 
measuring local cerebral metabolic rate of glucose in 
autoradiography, which included the dephosphorylation 
reaction, was applied to this PET study. 
For comparison between groups and individuals, PET 
FOG values were expressed as ratios of different brain 
areas in order to adjust for variability in absolute 
metabolic measure between individuals. Cortical and 
subcortical PET FO~ values were expressed as ratios with 
cerebellar values, a structure found to be relatively 
stable in mild to moderate OAT. Studies have found that 
P300 and PET 
such ratios are less variable in demonstrating regional 
differences in metabolic rate [27]. 
Results 
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The groups admitted for study were not significantly 
different in age compared either between normals and 
possible Alzheimer's dementia (PAD) or between the 3 CDR 
groups (CDR 0, 0.5 and 1.0). 
Figure 1 gives an example of the actual ERPs recorded 
from two PAD patients and controls. The shaded areas 
demonstrates the P300 component obvious in the difference 
between the response to the frequent and the rare stimuli. 
It can be seen that the P300 for the PAD patients are 
significantly longer than for the control. 
Insert Figure 1 about here 
Figure 2 presents the P300 latency z-scores for the 
normal control and two PAD groups. It can be seen that 
while all the normal patients fell below +1.5 SD of the 
normative group, 27 of 32 PAD patients exceeded norms by 
more than +2 SD. Remarkably, despite relatively mild PAD 
in the two patient groups, P300 latencies were grossly 
abnormal in a large number of cases. 
Insert Figure 2 about here 
P300 and PET 
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There was a significant difference in P300 latency z-
scores between the combined PAD group and the control 
group (p < 0.0005) and between the three CDR groups 
compared separately (p< 0.0005). The mean P300 measure for 
those with a CDR of 0 (normals) is significantly lower 
than those with a CDR rating of either .5 or 1.0 (p< 
0 . 0 0 3 ) (see Tab 1 e 1 ) . 
Insert Table 1 about here 
There is, however, no significant difference in P300 
latency z-score between those with a CDR of 0.5 and 
those with a CDR of 1.0 (see Table 1). 
A significant correlation was found between MMS 
and P300 z-scores (r= -0.59, p < 0.0005) for the three 
groups combined. As P300 latencies become longer, there 
is a decline in MMS scores. However, again within the 
patient groups, the P300 latency/MMS correlation was not 
significant (r= -0.21, n.s.). 
There was a significant negative correlation between 
P300 latency and cortical PET FDG ratios in the combined 
control and PAD groups. Specifically, there was a 
significant correlation demonstrated between P300 z-scores 
and Parietal/Cerebellum (p < 0.001); and 
Frontal/Cerebellum (p < 0.001); Temporal/Cerebellum (p < 
0.003); and Para-hippocampal/Cerebellum (p < 0.004) FDG 
P300 and PET 
ratios (see Figure 3). Thus, decrease in relative 
cortical metabolic rate for these structures was 
associated with a long P300 latency. There was no 
significant correlation with P300 latency for Caudate 
Thalamus/Cerebellum ratios or for the global measure of 
FDG uptake ratios (see Figure 3). This correlation was 
Insert Figure 3 about here 
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essentially carried by the pareital/cerebellum ratio. The 
frontal, temporal and parahippocampal ratios contributed 
only 0.12 combined. 
When P300 and PET measures were compared within only 
the PAD patients there was a significant correlation (p < 
0.006) for the Frontal/Cerebellum FDG ratio. There was no 
significant correlation for any of the other FDG ratios. 
(see Figure 4) . There were no significant PET/P300 
latency correlations when compared only within the control 
group (see Figure 4) . 
Insert Figure 4 about here 
Discussion 
These data demonstrate a number of important 
points about P300 latency in Alzheimer's type dementia. 
First, the data indicate that the P300 latency is 
sensitive to very early, mild forms of DAT. In this 
P300 and PET 
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sample of carefully diagnosed and screened, but marginally 
demented PAD subjects, 85% showed prolonged P300 latency 
at clinically detectable levels (i.e. > +1.5 SO). 
Although P300 does not discriminate within the PAD group 
(between CDR 0.5 and CDR 1.0), there is a significant 
difference in the P300 latencies even between the control 
and the 0.5 CDR group (i.e. those with only "possible" 
Alzheimer's dementia). Sensitivity of P300 to mild 
dementia was also seen in the significant correlation 
between P300 latency and MMS over a moderate range of MMS 
scores (i.e. >20) and P300 latencies. These data are 
thus consistent with the results of studies by Lai [21], 
and Brown, Marsh and LaRue [5]. 
Recent literature [31, 33] has brought into question 
the clinical usefulness of the P300 latency in the 
diagnosis of dementia. It was suggested that the P300 is 
only able to accurately detect major cognitive deficits, 
and would produce too many false negatives for persons 
with early, mild forms of dementia and too many false 
positive among "non-demented" psychotic individuals. 
Pfefferbaum et al. [31] used a more difficult paradigm 
with two infrequent stimuli and a wider standard deviation 
range, a standard error of regression being amost twice 
that of Goodin et al. [17], in the normative aging data 
than other studies. They found 20 to 30 percent of their 
P300 and PET 
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schizophrenic patients had P300 latencies which fell more 
than 2 SD above the mean while fewer that one/half of the 
P300 latencies of the demented group fell two or more SD 
beyond the mean for their age. In the Brown et al. [4] 
study there were no false positives meaning that no non-
demented person was classified as demented using the P300 
latency. They did find though that 7 of 26 demented 
patients were misclassified as non-demented using a cutoff 
of 2 SD beyond the mean for the patient's age. Polich et 
al. [33] reported that 31 percent of the demented patients 
fell 2SD beyond the age regression line and 54 percent 
fell beyond 1 SD of the regression line. The present data 
at least indicate that the P300 is sensitive to cognitive 
deficit associated with early, mild probable Alzheimer's 
disease. The P300 latencies of the patients were in many 
cases more than four standard deviations different from 
the latencies of non-demented subjects of similar age. 
The dramatic differences between groups in this study 
may be due to the very careful screening of both patients 
and controls. Most other studies of this problem have 
used mixed groups of dementias less well diagnosed and 
screened [31, 33] .. It is possible that DAT differs from 
other types of dementias in having relatively direct 
effects on P300 latency. Thus in a relatively pure DAT 
group the association between P300 latency and dementing 
P300 and PET 
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illness is stronger than found in studies including a less 
homogeneous group. 
A second major finding of this study is the 
relationship between P300 latency and cortical metabolic 
activity. From this study it can be observed that the 
P300 latency is a reflection of brain functional integrity 
as revealed in PET measures. Significant negative 
correlations were found between P300 latency and PET 
measures of metabolic rate. As the metabolic rate of the 
brain decreases, the P300 latency becomes longer. 
P300 latency appears to reflect primarily cortical 
metabolic activity. The correlations between the PET 
ratios and the P300 are significant for neocortical 
structure (i.e. parietal, temporal, and frontal) and 
archecortical (parahippocampus) structures of the brain. 
However, P300 does not appear to be related to relative 
subcortical metabolic rate, as manifested in PET measures 
from the caudate/thalamus. Nor is P300 latency associated 
with global measures of whole brain metabolic activity. 
From these data, it appears that the P300 latency is 
specifically sensitive to a decline in the metabolic rate 
of posterior brain regions, especially the pareital and 
temporal areas. These data correspond with the recent 
studies of Foster et al. [15] and Frachowiak et al. [16] 
of Alzheimer's patients which suggest that the pareital 
P300 and PET 
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and temporal areas show the earliest decline in metabolic 
rate with onset of the disease. Since a decline in 
metabolic activity in these areas are suggestive of early, 
mild Alzheimer's dementia, it can be suggested that the 
P300 shows promise in being useful for the diagnosis of 
early Alzheimer's dementia. 
P300 latency reflects the time required to complete 
demands of a task. The more difficult the task, the 
greater the time needed for completion. The P300 latency 
has been shown to be related to the processes associated 
with stimulus evaluation independent of reaction time. [11, 
27, 35]. This suggests that P300 latency is likely to be 
dependent upon the neural systems of the posterior 
pareital cortex which are involved in the perception, 
analysis and discrimination of stimulus information. This 
would be consistent with the PET/P300 latency correlations 
of this study. 
Much of the discussion regarding the cognitive 
significance of the P300 has focused on the relationship 
between P300 and memory functions. P300 amplitude has 
also been found to correlate with new learning [22]. P300 
amplitude was larger for learned items than new items but 
smallest for overlearned items, whereas P300 latency was 
longest for new items and shortest during overlearning. 
The authors suggest that new items may results in a 
P300 and PET 
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mismatch and updating of working memory or schema [10]. 
Memory span size nearly doubles between the ages of 5 and 
12 years [34]. Miller [24] suggested that the size 
increase stems from a change in the number of memory 
"slots" available to store information. It has been 
hypothesized [6, 34] that this developmental increase in 
memory capacity results in improvement in speed of mental 
operation processing. A relationship between memory 
performance as measured by the Digit Span task and P300 
amplitude has been found [18, 35], with better memory 
performance correlated with P300 amplitude. 
The P300 latency prolongation may reflect deficits in 
the ~mmediate memory of older patients, especially those 
with a dementing disease. Several studies [4, 17, 25, 38, 
39] have found increased P300 latencies associated with 
cognitive dysfunction for both young and old subject 
populations. Ford et al. [14] suggested that the elderly 
are slower at deciding what information was relevant 
causing an increased P300 latency especially as the amount 
of information needed to be remembered increased. 
Pritchard [35] reports that several studies found that 
P300 latency increased in a linear fashion with an 
increase in memory load. 
The decrease in memory functioning is suggestive of 
lowered metabolic activity in both temporal and 
P300 and PET 
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parahippocampal areas, thus we would expect to see a 
negative correlation between the P300 latency and 
metabolic activity of these areas. As the P300 latency 
increases, the metabolic activity observed in the 
pareital, temporal and parahippocampal areas decreases, 
important areas for the maintenance of an immediate memory 
trace and consolidation to longer term memory. 
There has been and continues to be controversy 
regarding the neural generators of the P300. Depth 
electrode studies have suggested [1, 26, 37] that the P300 
may be generated from the medial temporal lobe. But these 
studies have concluded that there are most likely multiple 
generators rather than a unitary source. It is probable 
that several generators may contribute to a unitary 
psychological function. Many neural generators may need 
to be activated to carry out a unitary psychological 
process [12]. Although depth electrodes P3s and scalp-P3s 
are not identical, Altafullah et al. suggests [1] that 
there is enough resemblance to make hypotheses regarding 
the generators. 
In investigating the PET scans of Alzheimer's patients, 
we are not able to trace the neural generators of the 
P300, but rather to demonstrate the brain systems whose 
integrity is necessary for the invoking of an early P300 
P300 and PET 
suggesting the ability of the brain to rapidly and 
efficiently complete mental processing. 
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In summary, a decline in cortical metabolic activity 
with the onset of Alzheimer's dementia, which initially 
appears most markedly in the pareital area of the brain, 
is a likely source of prolonged P300 latency found in DAT 
patients. Thus, prolonged P300 latency appears to be a 
sensitive index of diminished metabolic activity, 
particularly in cortical association areas. Clinical 
utility of P300 latency measures may thus lie not in its 
ability to detect dementia in every case or to 
differentiate dementias of different etiologies, but as a 
relatively direct measure of the integrity of cortical 
association areas. 
P300 and PET 
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Table 1 
Mans and Significance Levels 
AGE MMS P3(Z) P3(LAT) 
--------------------------------------------------------
c 
0.0 63.94 29.59 ab 0.0929 ab 334.7059 ab 
D 
0.5 65.89 25.00 c 3.1056 421.9445 
R 
1.0 68.43 22.71 ·3.3800 436.7857 
-------------------------------------------------------
a. Control different from all PAD patients 
(p < 0.0005) 
b. Control different from CDR 0.5, p < 0.0005. 
c. CDR 0.5 different from CDR 1.0, p < 0.0005. 
Figure Captions 
Figure 1 
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Sample ERP traces from normal controls (CDR=O.O), 
possible dementia (CDR=O.S) and probable dementia 
(CDR=l.O). Responses to the target and non-target tones 
are superimposed with the area of the P300 wave elicited 
by the target tone shaded. Recordings are from midline 
pareital (Pz), central (Cz) and frontal (Fz) leads 
referenced to an earlobe. Recording epoch is one second, 
with tone onset at 100 msec. Note that both PAD patients 
show longer P3 latencies than those of normal controls. 
For the traces illustrated in the right hand column 
(CDR=l.O) there appears to be a clear P3a (orienting 
response) and P3b (processing response) , the latter is the 
wave of interest. 
Figure 2 
P3 latency data converted to Z-scores for all subjects. 
From the left, columns are normal controls (CDR=O.O), 
possible dementia (CDR=O.S), and probable dementia 
(CDR=l.O). The dashed line represents the maximum Z-score 
value (1.8) for the normal controls of this study. Only 
five of the 35 patients fall within the range of normal 
subjects. 
Figure 3 
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Correlation of P3 latency (in z-scores) with PET 
measures. From left to right, bars represent correlations 
with the following PET measures: global metabolic rate; 
parietal metabolic rate divided by cerebellar metabolic 
rate (Pt/Cb); temporal divided by cerebellar (Tmp/CB); 
frontal divided by cerebellar (FT/Cb); parahippocampal 
divided by cerebellar (PHp/Cb) ; caudate-thalamus divided 
by cerebellum (Cth/Cb); and frontal divided by parietal 
(Ft/Pt). All correlations are positive when in the 
predicted direction (all negative except for the last 
column, Ft/Pt. The dashed line represents the two-tailed 
P< 0.5 level, adjusted for multiple comparisons. 
Figure 4 
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Correlation of P300 latency (in Z-scores) with PET 
measures for patient and control group separated. The 
dashed bars represent the patient group. The solid bars 
represent the control group. From left to right bars 
represent correlations with the following PET measures: 
global metabolic rate for patient and control; parietal 
metabolic rate divided by cerebellar metabolic rate 
(Pt/Cb); temporal metabolic rate divided by cerebellar 
(Tmp/Cb); frontal metabolic rate divided by cerebellar 
(Ft/Cb); parahippocampal metabolic rate divided by 
cerebellar (PHp/Cb) caudate-thalamus divided by cerebellum 
(CTh/Cb); frontal metabolic rate divided by parietal 
(Ft/Pt) and right perietal metabolic rate divided by left 
parietal (R/L Pt) . The dashed line represents the two-
tailed P< 0.5 level, adjusted for multiple comparisons. 
The correlation of the frontal metabolic rate for the 
patient group is the only PET measure that is significant 
when the groups are separated. 
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P300 and PET Research 
Alzheimer's Dementia: The Relationship Between P300 
Latency and PET Scan Ratios 
38 
The relationship between P300 latency and PET scan 
measures of focal cortical and subcortical metabolic 
activity was investigated in individuals considered to be 
early cases of probable Alzheimer's type dementia (PAD). 
The latency of the P300 component of auditory event-
related EEG potentials (ERP) has been suggested to reflect 
stimulus evaluation time, which increases significantly in 
most cases of neurological disease resulting in dementia. 
The Positron Emission Tomography (PET) provides a 
spatially discrete, quantitative, noninvasive measurements 
of the rate of physiological activity of the living human 
brain. 
The PAD patient group consisted of individuals 56-76 
years of age who scored below the normal range on the 
neuropsychological battery and exhLbited behavioral 
symptoms congruent with a diagnosis of mild dementia (MMS 
20-27). Non-Alzheimer types of dementia were ruled out by 
extensive medical evaluation. The control group consisted 
of individuals 52-71 years of age who fell within the 
normal range on a battery of neuropsychological tests (MMS 
28-30). 
An "auditory oddball" paradigm was utilized for P300 
measurement, (frequent tones 80%, target tones, 20%). 
Each subject was instructed to count the target tone to 
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her/himself. P300 latencies were expressed in z-scores in 
reference to the age/P300 regression line from a large 
population of normal elderly to control for age 
variations. 
Each patient and control underwent a glucose 
utilization PET scan using F-18 labeled 2-deoxy-2-fluror-
D-glucose (FOG) . PET values from different brain areas 
were reconstructed from multiple scans in the horizontal 
plane. Areas tested were expressed as ratios of 
cerebellar metabolic rate, a relatively stable structure 
in progressive degenerative dementia, to control for 
individual differences. 
A significant difference was found between PAD and 
normal subjects in P300 latency, with those in the patient 
group having longer P300 latencies than the control group 
(p< 0.0005). The P300 latencies were significantly 
correlated with cortical, but not subcortical, metabolic 
-
rates. The highest correlation was between P300 latency 
and parietal PET scores, with significant correlations 
also for frontal, temporal and parahippocampal areas. 
Results suggest that P300 latency is a sensitive measure 
of the functional decline in cortical association areas 
associated with early stages of Alzheimer's disease. 
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Alzheimer's Disease, P300 Component of Event-Related 
Potentials, and Positron Emission Tomography 
in Diagnosis and Research in Aging. 
40 
With the increase of life expectancy within the last 
century, we have had to confront new difficulties that 
accompany older age. One of these problems is one we have 
termed Dementia, a nonspecific clinical syndrome with an 
organic etiology characterized by the deterioration in 
intellectual, cognitive and psychological functioning. 
The diagnosis of dementia is based on a cluster of 
psychological as well as behavioral symptoms rather than 
on a causative factor. Often the specific causative 
factor is not confirmed until post-mortem. 
The criteria, according to DSM III, utilized to 
diagnose dementia include: (a) loss of intellectual 
ability resulting in social or occupational impairment; 
(b) memory impairment; (c) impairment in abstract 
thinking, judgment or higher cortical functioning or 
personality change; (d) retention of clear consciousness 
and (3) documented or presumed evidence of a specific 
organic cause. Various disorders producing dementia 
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include: Alzheimer's disease, Pick's disease, Creutzfeld-
Jacob disease and Multi-infarct, as well as disorders in 
which dementia is a significant, but not primary symptom~ 
Parkinson's and Huntington disease. There are also 
numerous metabolic and toxic states producing permanent or 
reversible dementia. 
Alzheimer's Type Dementia 
Alzheimer's Disease was first diagnosed in 1907 by 
Alois Alzheimer. It is now the most common cause of 
adult-onset dementia and is diagnosed in at least 50-55% 
of all cases of dementia (Tomlinson, Blessed & Roth, 1970~ 
Kuhl, Metter, Reige & Hawkins, 1985). Approximately 10-
15% (Price, Whitehouse, Struble, 1985) of persons over the 
age of 65 years will become at least mildly demented with 
50-60% of those suffering from Alzheimer's Disease. 
Physicians describe at least two forms of Alzheimer's 
(Lezak, 1983~ Barnes, 1987), one having an early onset 
around the age of 50, and the other having an onset much 
later. Local or personal preference seems to dictate 
whether dementia of the Alzheimer's type is considered a 
presenile dementia (called Alzheimer's disease) or a 
senile dementia (called senile dementia of the 
Alzheimer's type). Significant differences in rate of 
cognitive decline have been found (Lezak, 1983~ Loring & 
Larsen, 1985) between those patients with an early and 
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those with a late onset of Alzheimer's dementia. Those 
who have an early onset of Alzheimer's dementia are found 
(Loring & Larsen, 1985) to decline more rapidly and be 
more impaired than those with a later onset. Since 
identical patholologic changes and clinical features are 
found in both early and late onset dementia (Cummings and 
Benson, 1983), this does not necessarily designate two 
separate dementing diseases and thus this present 
discussion will use the terminology Alzheimer's Disease 
regardless of the age of the patient at onset. 
Clinical Features 
There are several observable clinical features that 
accompany the onset of Alzheimer's Disease including loss 
of memory, and disorders of language, praxis and 
perception (Price et al., 1985), with the earliest signs 
denoting Alzheimer's disease being a deficit in recent 
memory, depression and irritability (Lezak, 1976). 
Reisberg (1985) suggests seven phases in Alzheimer's with 
the first three phases, which include forgetfulness and 
early confusional states, indistinguishable from normal 
aging. The onset of diagnosable PAD occurs at stage four 
with deficit in areas of knowledge of current and recent 
events, memory of personal history, concentration and 
ability to travel, handle finances etc. 
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McKhann, Drachman, Folstein, Katzman, Price, and 
stadlan (1981) outline the criteria necessary for the 
diagnosis of probable, possible and definite Alzheimer's 
disease. These criteria include: dementia established by 
a clinical exam and documented by Mini-Mental Test, and 
Blessed Dementia Scale; deficits in two or more areas of 
cognition; no disturbance of consciousness; onset between 
40 and 90 years of age. A diagnosis of probable 
Alzheimer's disease is made if there is a typical 
insid~ous onset of dementia that is progressive and no 
other systemic or brain disease can account for the memory 
and other cognitive deficits. This diagnosis is supported 
by: impaired activities of daily living; family history 
of similar disorders; and laboratory results such as CT 
scan. A diagnosis of possible Alzheimer's disease may be 
made depending on the clinical course. Definite 
Alzheimer's Disease is not diagnosed until postinortem by 
autopsy. 
Cerebral Structure and Neurochemistry 
Alzheimer's Disease is characterized by atrophy of the 
cerebral cortex and dilation of cerebral ventricles. 
"There is evidence that cognitive deficits in Alzheimer's, 
especially memory, are related to a disorder of cortical 
cholinergic innervation associated with selective 
degeneration of cholinergic neurons whose cell bodies lie 
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in the basal forebrain." (Kuhl et al. 1985, p 419). In 
the past it was believed that patients with Alzheimer's 
show a selective degeneration of cholinergic neurons 
(Davis, 1979; Whitehouse, Price, Clark, Coyle, & Delong, 
1982). Foster, Chase, Mansi, Brooks, Fedio, Patronas, Di 
Chiro, (1984) brought this theory of selective 
degeneration of acetylcholine-releasing neurons into 
question, suggesting that this does not necessarily occur 
throughout the cerebral hemispheres from forebrain nuclei 
except in very the elderly. 
In a study of 17 drug-free Alzheimer's patients and 15 
normal subjects, Greenwald, Edasery, Mohs, Shah, Trigos 
and Davis (1985) found no significant differences in red 
blood cell choline, plasma choline or the ratio between 
the two. In a similar study Kanof, Greenwald, Mohs and 
Davis (1985) compared choline uptake into the red blood 
cells finding no difference in any kinetic parameters of 
red cell choline uptake between the Alzheimer's patients 
and controls. They did find a strong correlation between 
k and V values (calculated from Lineweaver-Burke plots 
d max 
and expressed in units of nanomoles choline per gram 
protein) for red blood cell choline uptake for the normal 
groups but not the patients. The authors suggest that 
this may be due to a selective vulnerability of central 
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resulting in an altered choline metabolism. 
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Price et al (1985) state that reductions in presynaptic 
markers for cholinergic neurotransmission are currently 
the most consistent neurochemical observation in 
Alzheimer's Disease. Dysfunction and death to cells in 
the areas of medial septum, diagonal band of Broca, and 
basal forebrain cholinergic system may be partially 
responsible for the reduction of cholinergic markers. 
The difficulty in diagnosing dementia is that the 
change in the cerebral anatomy is not necessarily 
different than that of normal aging. For some demented 
patients, a CT scan shows no cerebral atrophy (Duara, 
Grady, Haxby, Sundaram, Cutler, Heston, Moore, Schlageter, 
Larson & Rapoport, 1986). Others may show little or no 
change. Senile plaques and neurofibrillary tangles, which 
are believed to be partially responsible for the dementing 
process, are observable only at autopsy and are found in 
both demented and non-demented persons, although usually 
in different quantities in various regions. The 
distribution of amyloid plaques and neurofibrillary 
tangles in Alzheimer's appears to be more specific to the 
hippocampus, amygdala and cerebral cortex regions of the 
brain (Price et al, 1985< Barnes, 1987). However, this 
overlapping with normal brain aging, along with the 
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dependence upon behavioral signs for the clinical 
diagnosis of dementia in the living patient, often causes 
confusion between the various dementias, as well as 
between dementia and various other conditions which have 
similar behavioral features. This is especially true with 
elderly, depressed patients. 
Recent studies (St George-Hyslop, Tanzi, Polinsky, 
Haines, Nee, Watkins, Myers, Feldman, Pollen, Drachman, 
Growdon, Bruni, Foncin, Salmon, Frommelt, Amaducci, Sorbi, 
Piacentini, Stewart, Hobbs, Conneally & Gusella, 1987J 
Tanzi, Gusella, Watkins, Bruni, St. George-Hyslop, Van 
Keuren, Patterson, Pagan, Kurnit & Neve, 1987) have found 
a familial and chromosomal pattern in Alzheimer's patients 
suggestive of a genetic link. This research suggests that 
Alzheimer's, which has an early onset, may be caused by an 
inherited abnormal gene which is located in the same 
vicinity as chromosome 21. According to Tanzi et al. 
(1987) the highest level of expression of the beta protein 
gene was found in the association cortex, which may be 
related to some of the clinical symptoms observed with 
Alzheimer's. They hypothesize that this protein might be 
the basis of the inherited form of Alzheimer's. In 
addition research has shown (Sj~gren, Sj~gren, & Lundgren, 
1952) increased morbidity risk for family members of early 
onset Alzheimer's patients. 
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Changes in cerebral structure found in Down's Syndrome 
are identical to that of Alzheimer's Disease (Crapper, 
Dalton, Skopitz, Eng, Scott, Hachinski, 1975) which are 
believed to be a consequence of the same chromosomal 
defect as found in Down's patients. This defect is 
presented on the chromosome 21 (Reisberg, 1981). Price, 
Whitehouse, Struble, Coyle, Clark, DeLong, Cork and 
Hedreen (1982) compared changes in the cholinergic system 
of both persons with Alzheimer's Disease and older persons 
with Down's syndrome and found support for a cholinergic 
abnormality resulting from selective destruction of 
neurons in the nucleus basalis of Meynert. They also found 
a link between the selective lesion in the nucleus basalis 
of Meynert and the cortical cholinergic deficiency which 
may be responsible for the formation of neuritic plaques. 
It has been stated (Reisberg, 1981) that 100% of person 
with Down's syndrome who live into middle life will 
develop a clinical and pathological condition identical to 
Alzheimer's Disease. The incidence of Down's syndrome is 
higher in families of individuals with Alzheimer's 
disease. 
Neuropsychological Evaluation 
Clinical neuropsychology presents one non-invasive 
technique for the evaluation and diagnosis of dementia in 
the elderly, as well as the differentiation from 
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depression or other psychiatric, treatable conditions. 
Albert (1984) categorizes mental functions into five basic 
areas: attention, language, memory, visuospatial ability 
and conceptualization. Numerous standardized test have 
been developed for the assessment of these areas for both 
impaired and non-impaired. Research suggests (Lezak, 
1983) that patient's with Alzheimer's Disease retain 
functions that are familiar and overlearned longer (i.e. 
scores on WAIS subtests Information, Vocabulary, many 
Comprehension and Similarities items, and Digits Forward 
are highest) than unfamiliar, abstract, and speed-
dependent tasks (i.e. WAIS Block Design, Digit Symbol and 
Digits Backward are often the lowest scores obtained). 
Immediate span and short-term memory tend to be spared 
(Lezak, 1983), whereas subtle language deficits can appear 
very early in the disease. 
Persons with delirium or clinical depression will 
exhibit attentional deficits whereas individuals in the 
early stages of a dementing disorder can often perform 
simple attentional tasks within the normal range (Albert, 
· 1984). This area can be assessed by using Digit Span 
forward, a simple and easily administered test of 
attention. 
Albert (1984) suggests that a comprehensive 
aphasia examination be administered to assess the degree 
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of impairment in comprehension, repetition, reading, 
writing and naming abilities. The Boston Naming Test 
(Kaplan, Goodglass & Weintraub, 1978), The Multiple 
Choice Naming Test (Huff, Corkin & Growdon, 1983), and 
The Category Fluency Test have been utilized (Huff & 
Corkin, 1984) to assess the presence of aphasia in 
Alzheimer's patients. While there do not appear to be 
consistent deficits in naming ability with either 
depression or delirium, persons with early Alzheimer's 
Disease will show disturbances in naming. They will often 
make circumlocutory errors or errors of association. 
Memory loss is characteristic of early Alzheimer's 
Disease, but can also be seen in individuals with clinical 
depression. In contrast to the person with dementia, the 
depressed person tends to recall as much or sometimes more 
following a delay, whereas the demented patient will show 
a dramatic loss of information following a delay. Thus 
memory assessment should include both immediate and 
delayed memory tests according to Albert (1984). 
Visuospatial skills can be assessed with a simple 
copying task. Deficits in visuospatial tasks will also be 
seen with the Alzheimer's patient. These patients will 
show the decline in visuospatial skills seen with normal 
aging such as slowing in ability to complete the tasks, 
but may also demonstrate perseverative tendencies such as 
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repeating an earlier drawing. According to Albert (1984) 
the "average mildly to moderately impaired Alzheimer 
patient can generally perform simple visuospatial tasks 
quite well" (p. 316), but there is a subgroup whose 
copying performance is grossly distorted and they often 
complain of "not seeing right". Albert stated that with 
this subgroup, the perceptual abilities are almost always 
more severely effected than their memory performance. 
Proverb interpretation, Similarities, card sorting, 
maze learning and list generation are tests suggested 
(Albert, 1984) for the assessment of conceptualization. 
The Alzheimer's patient will demonstrate significant 
impairment in conceptualization of abstract information. 
They tend to be much more concrete that those with normal 
aging deficits. 
Feher, Largen, Barr and Smith (1984) found Alzheimer's 
patients to fall significantly below the normal on a wide 
range of neuropsychological tests including scores on the 
WAIS Verbal, Performance and Full Scale IQ, Buschke 
Selective Reminding Test, Dementia Rating Scale, Seashore 
Rhythm Test, Digit Cancellation Test, Hidden Words Test 
·~ 
and the Wechsler Memory Scale Visual Reproduction subtest. 
Storandt, Botwinick, Danziger, Berg and Hughes (1984) 
were able to correctly classify patients with mild 
Alzheimer's Disease from normal, healthy older adults 
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utilizing a battery of tests which included: Wechsler 
Memory Scale, Word Fluency Test, Boston Naming Test, 
Entertainment Questionnaire, Visual Retention Test, 
Wechsler Adult Intelligence Scale, Trailmaking A and a 
Depression scale. From this list of tests given they 
found that with a short battery which included only WMS 
subtests logical memory and mental control in addition to 
Trailmaking A and Word Fluency 98% of the subjects were 
correctly classified. 
Pseudodementia 
Depressive pseudodementia is the term often used for 
patients who appear to have suffered a loss of cognitive 
functioning, but who in reality are experiencing moderate 
to severe depression. This condition is reversible if 
treated, and thus the importance of a correct differential 
diagnoses is apparent. Depressive symptoms which mimic 
dementia include: apathy, psychomotor retardation 
impaired memory and judgment, orientation and intellectual 
functions such as comprehension, calculation and general 
knowledge. Thus a common source of error in the diagnosis 
of dementia is in those suffering from depression or 
transient confusional states. Wells (1979) lists the 
following distinctions between dement,ia and depressive 
pseudodementia: in pseudodementia the person exhibits 
short duration of symptoms, rapid progression of the 
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difficulty, previous psychiatric dysfunctions, pervasive 
affective changes, vociferous and detailed complaints of 
cognitive impairment, "don't know" rather than the near-
miss answers, variability of performance, well-preserved 
attention span and concentration. 
There is controversy regarding the use of the 
terminology, depressive pseudodementia. Post (1975) 
considers the category to be unimportant, stating that a 
differential diagnosis can be made between depression and 
dementia. Shraberg (1978) regards the category to be 
merely a myth. Reifler, Larson and Hanley (1982) found 
the concept to be of very little use. 
The misdiagnosis of dementia, however, has serious 
consequences. The treatment of the patient may be 
terminated upon the diagnosis of most types of dementia 
since they are progressive and non-reversible. The 
patient may be placed in a nursing care facility and 
negative attitudes within and toward the patient may 
develop. Families may withhold necessary emotional 
support. 
Thus, there is a need for more precise and objective 
means of diagnosing dementia in the elderly. The P300 
component of auditory event-related potentials (ERP) has 
shown promise for making a significant contribution to the 
evaluation of cognitive functioning. 
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P300 Component 
The P300 (also referred to as P3) is the third 
positive wave in the ERP which peaks at approximately 300 
msec following the onset of a task-relevant, rare 
stimulus. The P300 is termed an "endogenous" component of 
ERP's because it is reliant upon an internal evaluation 
process of the stimulus by the subject. Pritchard (1981) 
suggests that the P300 is the actual phenomenon of 
interest rather than being used merely as a measure for 
drawing inferences regarding a different phenomenon of 
interest. Therefore the question to be asked is what 
correlates with P300. In fact there are many variables 
which correlate with the presence or absence of P300 such 
as: stimulus probability; classification of stimuli 
(signal or nonsignal); and task relevance. Depending on 
the instruction given to the subject, the stimulus will 
serve in one of these various functions. Thus, the same 
stimulus may or may not result in a P300. Based on this 
differentiation, Pritchard suggests that the P300 is 
"invoked" rather than "evoked". The variations of the 
experimental context result in an internal change as the 
subject evaluates the stimulus. 
Two conditions are required to elicit a P300 wave: 
(a) a low probability stimulus, and (b) a discriminative 
task given to the subject. Typically an "auditory 
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oddball" paradigm is used to elicit a P300. Regularly 
occurring auditory stimuli of a given pitch are 
occasionally and randomly replaced with ones of a 
different pitch and/or intensity. The infrequently 
occurring stimuli are made task-relevant by having the 
subject count them. Averaged evoked EEG responses 
elicited by the counted, infrequent stimulus manifest a 
large positive wave (P300) which is not apparent in the 
response to its frequent stimulus. P300 disappears in the 
response to rare stimuli if the subject ignores them. 
Donchin (1981) states that P300 latency is not an 
orienting response. He found that orienting responses 
habituate. Once the stimulus is not longer novel, the 
response does not occur. P300 does not habituate, nor 
does it disappear while the person is involved in the 
stimulus task. He suggests that the P300 is involved with 
the process of memory modification or learning, and the 
process manifested by P300 is association with the 
updating of our schema. 
P300 Amplitude 
Past research (Pritchard, 1981) has demonstrated that 
P300 amplitude and latency systematically correlate with a 
number of specific cognitive manipulations. Sutton, 
Braren, Zubin and John (1965) were the first to sugge~t a 
relationship between P300 amplitude and uncertainty 
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resolution (information delivery) . P300s were invoked 
when the stimulus supplied the subject with information 
(Pritchard, 1981). But it was soon discovered that 
uncertainty resolution did not offer enough explanation of 
the phenomenon of P300 amplitude. 
In his review of the P300, Pritchard (1981) found P300 
amplitude to decrease as the subject's confidence in 
his/her own perceptions decreased. P300 amplitude 
is larger following signals than nonsignals which 
indicates the involvement of an interaction between 
incoming information and memory. Increased memory 
capacity and functioning, which occurs with normal 
development, is significantly correlated with 
P300 amplitude. Also, there is evidence that P300 
amplitude invoked by task relevant stimuli is a function 
of the actual use of the information by the subject. As 
subjects master a trail-and-error concept-formation task, 
P300 amplitude decreases. Furthermore, P300 amplitude 
can, under some conditions, be predicted by the subject's 
expectancy regarding signal presentation. P300 amplitude 
does appear to index perceptual limited-capacity 
processing, meaning that when a P300 component is 
observed, the subject was conscious of the stimulus that 
preceded the component by roughly 300 msec. Polich (1986) 
found in studying students with no neurological or 
P300 and PET Research 
56 
psychological disorder that the amplitude of the P300 
was affected by how conscientiously the subject is 
involved in the task, i.e. attention. P300 amplitude is 
sensitive to perceptual load (Donchin, 1981). If 
perceptual demand for other concurrent tasks increases, 
P300 amplitude in the original task decreases. 
P300 Latency 
Duncan-Johnson and Donchin (1979) and Duncan-Johnson 
I 
(1981) suggested that the P300 latency is a useful index 
of the duration of stimulus-evaluation processes 
independent of the time necessary for stimulus selection 
and response execution. Stimulus-evaluation processes are 
defined as "the subset of cognitive operations involved in 
the encoding, identification and categorization of a 
stimulus" (p. 209). Duncan-Johnson and Donchin (1979) 
recorded ERPs and response times (RT) from 12 male 
subjects using a warned, choice RT task. The subjects 
were presented with a series of visual stimuli that fell 
into one of three categories; match, mismatch or star. 
The probability of the various stimuli appearing changed 
over the course of the series. Conditional probability 
was found to be the principal determinant of P300 and RT. 
The lower the probability, the later the P300 and the 
slower and less accurate the response. It was concluded 
that P300 can be used as a measure of stimulus evaluation 
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Duncan-Johnson (1981) concluded that P300 is not merely 
another measure of response time, like a motor reaction 
time, but is in fact free from response-related factors. 
This hypothesis has found support from many studies 
(Squires, Donchin, Squires & Grossberg, 1977; Donchin, 
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Ritter & McCallum, 1978; Ford, Hink, Roth, Pfefferbaum, & 
Kope 11 , 1 9 7 9) . 
Picton, Stuss, Champagne and Nelson (1984) found 
no change in reaction time with age. They suggest that 
the P300 component is initiated in young adults at 
approximately the same time as a motor response, although 
the P300 compenent is independent of response time. With 
aging the P300 process occurs later than reaction time. 
They suggest that there are two parallel processes 
occurring in the brain, one generating the reaction time 
the other a cognitive event which is manifested in the 
P300 latency. 
Fitzgerald and Picton (1983) found that increasing the 
difficulty for detecting target stimuli prolonged the 
latency of the P300. They conducted a series of three 
experiments in which the target stimuli were varied in 
degree of detection difficulty on 19 subjects ages 17 to 
37 years. The frequency of occurrence and number of target 
stimuli were varied. Subjects were instructed to count 
P300 and PET Research 
or press a button upon hearing the target stimulus. 
Fitzgerald and Picton found that the P300 component was 
significantly smaller in amplitude and prolonged in 
latency for the more difficult target compared with the 
easily detected stimulus. This result occurred in all 
three experimental conditions. They postulated that the 
amount and type of updating that occurs in the final 
stage· of stimulus discrimination is indexed by the P300 
component. 
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Hillyard, Squires, Bauer and Lindsay (1971) found the 
P300 amplitude to increase as the confidence of the subject 
regarding correct signal detection increased. Paul and 
Sutton (1972) were able to confirm this hypothesis 
adding the relationship between the P300 compenent and 
response bias to the confidence explanation. 
Fourteen subjects ranging in age from 19 to 31 years 
were studied by Brookhuis, Mulder, Mulder and Gloerich 
(1983), using a visual task which increased in the amount 
of information that needed to be remembered. They found 
that there was an overall main effect for the processing 
load. The P300 latencies were affected by the time needed 
to make either a positive or negative decision but not by 
response time. P300 latencies increased as a function of 
processing load or increased task difficulty. Ford, Roth 
and Kopell (1976) and McCarthy and Donchin (1981) also 
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difficulty increased. 
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Ford, Pfefferbaum, Tinklenberg and Kopell (1982) 
studied the P300s and response times of 10 elderly (mean 
age 79 years) and 10 young (mean age 23 years) female 
subjects each receiving a series of visual memory 
retrieval tasks. Subjects were instructed to press a 
button with the index finger of one hand if the probe was 
a positive and press the other button.with the index 
finger of their other hand if the probe was negative. The 
Stimuli were numbers constructed with unconnected dots. 
Some stimuli were degraded by adding random dots making 
the identification more difficult. They found that P300 
latency was longer for the elderly subjects than for the 
young as reported by others (i.e., Ford et al; 1979; 
Pfefferbaum et al; 1980a). The also found that increasing 
the difficulty of the memory set from 2 to 4 prolonged the 
P300 latency for the young subjects but not for the 
elderly. This finding supports that of Pfefferbaum et al. 
(1980). Ford et al. suggest that operations designed to 
make the decisions more difficult (e.g, increasing memory 
load) do not affect P300 latency but those designed to 
make the discrimination more difficult (degrading) do 
affect P300 latency. 
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McCarthy and Donchin (1981) manipulated the stimulus 
difficulty by visually presenting the word "right" or 
"left" surrounded by either the # sign or other random 
letters. In addition the word "different" or "same" 
appeared on the screen indicating which hand the subject 
was to use in responding. They found that the P300 
latency was affected only the presence of noise (the words 
surrounded by random letters) but not the incompatible 
response instructions (different, meaning if the stimulus 
word was "right" respond with your left hand). McCarthy 
and Donchin suggest that their data indicate that the P300 
can serve as a dependent variable for studying human 
information processing. 
Polich (1986) studied 12 normal subjects between the 
ages of 18 and 24 years using variations in frequency and 
intensity of the target tone to determine the effect upon 
P300 latency. He found that P300 latency was not 
significantly affected by variable of attention but was 
stable, varying little as a function of the task when the 
subject was engaged in a discrimination paradigm of some 
type. A decrease in P300 latency was found when subjects 
were asked to ignore the stimuli. Polich commented that 
even when given instructions to ignore, there appeared a 
P300 which he suggests may be an indication that some 
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information processing occurs even when told to ignore the 
stimulus. 
P300 Generators 
Much discussion has occurred regarding the location of 
the neural generator(s) of the P300. Depth electrode 
implantation has offered general information of possible 
areas where P300 generators may lie. Altafullah, Halgren 
Stapleton and Crandall (1986) studied responses from 
electrodes implanted in the hippocampus, parahippocampal 
gyrus and amygdala of 16 patients with partial complex 
epilepsy in order to lateralize seizure activity. They 
found support for local generation of the P300. Although 
the Medial Temporal Lobe (MTL)-P3 is not identical to the 
scalp-P3, they appear to be very similar. They suggest 
that MTL may generate a significant portion of the scalp-
P3 with the late posterior and lateral P300 reflecting 
more MTL activity than the earlier fronto-midline P300 in 
simple tasks. They found that the scalp-P3 was about 
twice as large as expected suggesting that the MTL is not 
the sole source of activity resulting in a scalp-P3. This 
theory has found support by other investigators (Smith, 
Stapleton & Halgren, 1986~ Halgren et\al, 1980, 1985a~ 
Squires et al, 1983 and Wood et al, 1984). Smith, 
Stapleton and Halgren (1986) found that MTL-P3 changes 
during recognition memory tasks were small or absent to 
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suggest that MTL-P3 might indicate the completion of MTL 
involvement in memory search and retrieval operations. 
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According to Okada, Kaufman and Williams (1983), an 
endogenous potential (200-630 msec) appears at the scalp 
when a subject is involved in tasks requiring judgment 
about a stimulus. Intracranial recordings have found 
increased single unit firing in or near the hippocampal 
formation and amygdala while subjects were engaged in 
task-relevant activities. In their study of 3 young 
adults using magnetic and electrical recordings, Okada et 
al. suggest that their data strongly support the 
hippocampal formation as the location of the major source 
or sources of P300 for at least the right hemisphere. 
These studies suggest the possibility of multiple 
generators of the P300 component. It has been discussed 
in light of this indication (Fabiani, Gratton, Karis & 
Donchin, in press) that multiple generators does not mean 
multiple psychological processes are also involved. Many 
neural generators may be involved in order to activate and 
carry out a unitary psychological process in diverse brain 
regions. 
P300 and Memory 
Howard and Polich (1985) studied 24 children 
(5-14 years) and 24 adults (20-40 years) using the Digit 
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Span subtest of the Wechsler Adult Intelligence Scale 
(WAIS) . They found that as memory span increased, P300 
latency decreased for the children relative to the adults. 
They suggested that perhaps fewer resources are utilized 
for encoding and item-identification processes when the 
memory capacity is more developed, thus the shorter P300 
latency. 
Polich (1986) observed the ERPs of 100 undergraduates 
(mean age 20.4 years). He found P300 amplitude and 
latency to be negatively correlated implying a systematic 
relaiionship with the association the greatest at the 
parietal/central scalp locations. His data support 
Donchin's {1981) theoretical interpretation of the P300 as 
relating "incoming sensory information to memory updating 
processes" (Polich, 1986; p. 239) as well as 
neuropsychological observations that the parietal lobe 
engages in such activities. 
M~ntysalo and Gaillard {1986) studied ERPs of 9 normal 
male subjects while completing a syllable learning task. 
P300 latency was found to be longest for new syllables and 
shortest during overlearning. They suggest that the P300 
invoked during the test phase when new syllables were 
being introduced, could be associated with the updating of 
working memory. They indicate that this updating may 
occur by a match/mismatch function, a prolonged cognitive 
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process manifested in a long latency P300. P300 amplitude 
was found to be largest for learned items but smallest for 
overlearned items during a word recall task. These data 
suggest that the evaluation of unlearned items takes 
longer resulting in longer P300 latencies, than the 
evaluation of just learned items which elicit larger P300 
amplitudes. 
Donchin (1981) proposes that the P300 is involved in 
the process of memory modification or learning. Responses 
that are to be remembered may possibly be those processes 
manifested by the P300. He presented subjects with a 
series of words displayed one at a time with half of the 
words appearing dimmer on the screen. The subject was 
told to memorize the dim words. The subject is then 
tested with all words appearing at the same intensity. He 
found large differences between the ERPs elicited by the 
words that were dim during the training phase, and those 
that were bright during the training phase. These 
differences were not attributable to the intensity of the 
words because all words were the same intensity during the 
testing phase, rather the P300 differences are due to the 
subject attempting to identify the words that were to be 
remembered. 
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P300 and Normal Aging 
Changes have been found (Courchesne, 1977: Courchesne, 
Ganz & Norcia, 1981) in the P300 that correlate with 
cognitive development in children. P300 latency decreases 
from the ages of 5 to puberty, then stabilizes and then 
increased with age. Marsh and Thompson (1972) were 
perhaps the first to report age differences in P300 
latency measurements using auditory discriminative tasks. 
An increase in latency was seen for normal elderly 
individuals. This was substantiated later by other 
investigators (i.e, Brent, Smith, Michalewski & 
Thompson, 1977: Ford, Roth, Johns, Hopkins & Kopell, 1979) 
Pfefferbaurn, Ford, Roth & Kopell, (1980a: 1980b) found 
similar results with P300 and normal aging from data 
collected from 8 elderly (74-90 years) and 12 young (20-29 
years) healthy, normal women. The subjects were given 
visual memory retrieval tasks and P300 recorded. They 
found that the elderly subjects differed significantly 
from the younger subjects in three major areas: (a) P300 
amplitude at Pz was smaller for the elderly: (b) P300 
latency and response time were slower for the elderly 
group: and tc) the relationship between P300 and response 
time was altered, less tightly coupled. There was a 
significant difference, not age related, in P300 latency 
between the young and elderly groups, although there was 
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correlations. These results were substantiated 
(Pfefferbaum, Ford, Wenegrat, Roth & Kopell, 1984) with 
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a larger number of subjects and utilizing computerized 
measures of P300 latency and single as well as averaged 
trials. In addition to the findings that P300 latency 
increases with age, they also found that scalp topography 
of the P300 changes with age. P300s in young subjects 
have a parietal distribution. With age, the P300 becomes 
more frontally distributed. 
Goodin, Squires, Henderson and Starr (1978) found that 
P300 significantly increases with age in a linear fashion 
at a rate of 1.2 msec per year. Syndulko, Hansch, Cohen, 
Pearce, Goldberg, Montan, Tourtellotte, and Potvin (1982) 
found latencies to increase .7 at Fz, 1.0 at Cz and 1.1 
msec per year at Pz. Pfefferbaum, Wenegrat, Ford, Roth, 
and Kopell (1984) found an increase of 1.0-1.5 msec per 
year in P300 latency. Brown, Marsh, and LaRue (1983) 
further found that a exponentially accelerating curve 
describ~d the P300 latency/age interaction more precisely 
than merely a straight line. They studied 49 normal 
subjects (15-80 years) using a modified version of the 
"auditory oddball" paradigm. They suggested that the 
slope for the regression line was different for persons 
under 45 years of age than for those over 45 years. They 
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found that the P300/age correlation for subject under 45 
years was not significant, whereas for those over 45 years 
of age, the P300/age correlation was highly significant 
and yielded a linear slope of 3.14 msec/year. They 
suggest that P300 latency is a positively accelerating 
function of age. 
Picton, Stuss, Champagne and Nelson (1984) found no 
evidence of a curvilinearity in the regression line of 
P300 latency for normal aging in their study of 72 
subjects ages 20-79 years. They suggest that in addition 
to the linear age effect on P300 latency there may also be 
other variables related to subject selection which affects 
P300 latency and may bring out a curvilinearity in the age 
regression. 
P300 and Dementia 
The latency of the P300 increases beyond the effects 
of age, in most cases, for persons with a neurological 
disease which results in dementia, whereas persons with 
functional disorders or neurological disease without 
cognitive impairment rarely exhibit an increase in P300 
latencies (Goodin et al. 1978; Squires, Chippendale, 
Wrege, Goodin, & Starr, 1980; Brown, Marsh & LaRue, 1982). 
Brown, March and LaRue (1982) studied 24 elderly (50-81 
years) normal subjects and an inpatient group of 25 
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individuals (65-88 years) who had been admitted to the 
hospital for treatment. The patient group consisted of 
individuals diagnosed with Alzheimer's Disease (10), 
multi-infarct (5), dementia associated with Parkinson's 
Disease (3), and depression with no dementia (7). 
Utilizing the P300 latencies from an auditory oddball 
paradigm, to diagnose the subjects, they found that no 
psychiatric cases were classified as demented (i.e. these 
did not fall outside 2 SD of the age/P300 regression 
line) . Whereas three non-demented patients were 
classified as demented with the MMS, there were no false 
positives using P300 latency. False negative (failing to 
detect the presence of dementia) occurred in 7 of 17 
patients using the P300 latency. It was suggested that 
the P300 and the MMS could be used in conjunction for the 
most accurate differential diagnosis of patients as 
demented or non-demented (i.e. depressed). 
Syndulko et al. (1982) replicated the findings of 
Goodin et al. (1978) focusing more specifically upon 
elderly patients with the diagnosis of moderate 
progressive dementia. Their findings suggest that not 
only is the P300 latency useful to discriminate functional 
from any dementing disorder, but specifically from primary 
dementing disorders. 
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In contrast to these studies, Pfefferbaum, Wenegrat, 
Ford, Roth and Kopell (1984b) concluded that the P300 
latency is not sensitive enough for clinical diagnoses. 
They studied three inpatient groups, one consisted of 
patients who demonstrated clinical evidence of cognitive 
impairment and two groups who met criteria for 
schizophrenia and major depression (Research Diagnostic 
Criteria, Spitzer & Endicott, 1978). They found that 
although there were differences in P300 latency and 
amplitude in the three groups, they were not large enough 
nor specific enough for clinical differentiation. The 
demented group had significantly prolonged P300 latencies, 
but less than 50% fell 2 SD outside the predicted age 
related score. Twenty to thirty percent of the 
schizophrenic patients had P3 latencies more than 2 SD 
longer than the mean for their age. 
Lai (1984) suggested that these conclusions may be a 
result of the fact that the schizophrenic subjects were 
chronic patients medicated on neuroleptics. It is quite 
likely that some of these patients were also in fact 
organically impaired. 
P3a 
A moderate number of false negative diagnoses for 
dementia using P300 may be accounted for by the 
confounding occurrence of "P3a". Squires, Squires, & 
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Hillyard, (1975) differentiated an early P300 wave (P3a) 
from a later occurring P300 wave (P3b) . The P3a peaked 
between 220-280 msec in young normals and had a frontal 
scalp distribution when these subjects were asked to 
ignore the stimuli. When asked to count the rare stimuli, 
the P3b occurred at 310-380 msec with a parietal scalp 
distribution. P3a was not found in all cases of active 
attention, while at other times it could be seen 
superimposed upon a P3b component. Thus, P3a appears to 
occur in both active and passive conditions, although it 
may be obscured in the active condition by the P3b. P3a 
may be an index of a basic sensory mechanism which 
registers any change in background stimulus and thus can 
be interpreted as an orienting response. Ford, Roth et 
al, (1976) confirmed the existence of P3a. 
In the case of patient testing, it is likely that a 
P3a would occur without a P3b in those persons who are 
unable to understand or retain the instructional set. 
However, failure to recognized the wave as P3a may lead to 
the conclusion that the P300 (P3b) was within normal 
limits, and that the person was not demented. Thus it may 
be that the early P300 wave found in some clearly demented 
patients was in fact a P3a. Thus measurement of P3a 
rather than P3b would result in false negatives for 
dementia. 
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Lai et al. (1985) have demonstrated that the P3a 
confounded the measurement of P300 (P3b) , and subsequent 
diagnosis, in two ways; (a) in some cases P3a preceded P3b 
as an inflection of a fairly distinct wave or (b) P3a was 
the only P300 wave elicited to the infrequent stimulus. 
This often occurred in severely demented patient. Lai et 
al. (1985) added a third surprising tone which was non-
task-relevant to the typical "auditory oddball" paradigm 
in order to elicit P3a in isolation. Also the stimulus 
differentiation was made more difficult by eliminating the 
intensity differences between target and frequent tones. 
This was thought to increase P3b latencies in elderly 
patients. Thus P3a and P3b would be more distant. 
Lai et al. (1985) found the expected decreasing 
amplitude from posterior to anterior for P3b, and an 
increasing amplitude from posterior to anterior with the 
P3a. P3b was found to be significantly different in 
latency between the normal and patient groups, but P3a 
measurements were not different. For patients with Mini-
Mental State scores greater than 26 and less than or equal 
to 26, P3b was again significantly different while P3a was 
not. 
Contrary to earlier suggestive evidence (Brown et al, 
1982), Lai et al, (1985) found that P300 latency did not 
appear to discriminate Primary Degenerative Dementia from 
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Multi-infarct or Parkinson Dementia. Polich et al. 
(1986) also found no statistical difference between 
different diagnoses of dementia and P300 latencies. It 
appears from these studies that at least for group 
averages the dementing illnesses produce similar effects 
on P300 latency and amplitude across etiologies. The many 
factors which contribute to a variety of dementing 
illnesses apparently have some relatively common factor 
which serves to increase the P300 latency independent of 
age related changes. Thus P300 latency measurements may 
prove to be an important tool in the differential 
diagnosis between demented and non-demented patients, but 
thus far does not provide information regarding various 
possible etiologies of dementia. 
One possible cause for the occurrence of a P300 
outside the normal range for some demented persons and not 
for others could be the sensitivity of the P300 latency to 
cortical integrity within specific brain regions or 
systems. That is, regardless of the global level of 
dementia, certain specific neural tissue must be 
dysfunctional for P300 latency to become abnormally long. 
Thus, different an~tomical progressions or different 
stages of various dementing processes may or may not 
impinge on neural systems influencing P300 latency. 
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Positron Emission Tomography 
With the new advances of the Positron Emission 
Tomography (PET), it is now possible to measure the 
metabolic activity of specific brain regions in living, 
active patients. The earliest and most specific changes 
occurring in various diseases of the brain are reflected 
in disturbances of underlying biochemical processes and 
thus are apt to be detectable by PET scanning. 
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Three major components are required in order to 
obtain quantitative ratios of biochemical activity using 
the PET scanner: injectable compounds labeled with 
radioisotopes, the positron tomograph, and tracer kinetic 
mathematical models. 
Radionuclides such as Fluorine-18 can be used to 
label biological substrates or analogues such as glucose 
or water and then be injected into the blood stream of the 
subject. This short-lived radioisotope then circulates and 
otherwise interacts in a normal physiological manner. In 
the case of Fluorine-18 labeled glucose the radioisotope 
is thus taken up into active neural tissue. The greater 
the activity level of specific tissue, the greater the 
uptake of the radioisotope. The isotope Flurodeoxyglucose 
is a very unstable form of fluorine with as half-life of 
approximately 17 minutes. It is quickly transported to· 
the brain since glucose is the only source of energy 
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utilized by the brain. Trapped with active neural cells, 
the unstable isotope releases an unequal number of 
electrons and protons resulting in collisions which form 
the very energetic gamma rays. 
The tomograph is an array of radiation detectors 
placed circumferentially around the head of the patient. 
These detectors record the emission of gamma rays from 
the tissue distribution of positron activity within neural 
tissue which has taken on the radioisotope by normal 
physiological activity. The data collected are then 
processed by a computer to form a tomographic brain image. 
Images can be constructed for multiple 2-dimensional 
planes, comprising in all a 3-dimensional image of brain 
physiological activity. Thus PET provides a spatially 
discrete, quantitative, noninvasive measurements of the 
rate of physiological activity of the living human brain 
in three-dimensional perspective. 
Tracer kinetic models represent mathematical 
descriptions of biochemical reaction sequences. Each 
segment of the sequence is a compartment, and differential 
equations describe the movement of the natural labeled 
compounds between the compartments. Measurements are made 
of the flux between compartments which are then used to 
determine the rate at which the reaction sequence 
proceeds. These reaction rate calculations form the 
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numerical basis of the digital brain image created by 
positron emission tomography. 
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Due to the short half-lives of the positron-emitting 
isotopes, it is possible to perform multiple studies in a 
single setting to observe the effects of changes in 
spontaneous or stimulus-induced alterations on regional 
brain' distributions of different biochemical processes. 
PET and Normal Aging 
The study of cerebral blood flow (CBF) and cerebral 
metabolism in normal aging as well as dementia has yielded 
contradictory results. Some researchers (Kety, 1956; 
Navitomi, Meyer, Sakai, Yamaguchi, & Shaw, 1979) suggest 
that CBF and cerebral metabolism decrease with age. 
Others (Butler, Dastar, & Perlin, 1965; Fujishima, & Omae, 
1980) report no change. De Leon and his associates (De 
Leon, Ferris, George, Christman, Fowler, Gentes, Reisberg, 
Gee, Emmerich, Yonekura, Brodie, Kricheff and Wolf, 1983) 
studied PET scans of 15 young normal subjects (mean age 
26.1), 22 elderly normal subjects (mean age 66.6), and 24 
mild to severe Alzheimer's patients (mean age 73.4). 
Their results failed to demonstrated any significant 
difference in glucose metabolism due to normal aging 
although there was a trend toward decreased metabolism 
within the older normal group. 
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PET and Dementia 
All diseases of the brain result from'or produce focal 
or diffuse biochemical changes, reflective of functional 
brain disturbance. PET images display functional 
processes, often demonstrating larger, earlier and more 
distributed lesions than those found in anatomically 
oriented techniques (CT or MRI scans) . Significant 
correlations exist between the PET measures of glucose use 
and the measures of cognitive functioning in demented 
patients (de Leon et al. 1983). The cognitive deficits of 
Alzheimer patients may have focal as well as a generalized 
decrease in cerebral glucose metabolism (Foster, Chase, 
Fedio, Nicholas, Patronas, Brooks, & Di Chiro, 1983). 
The PET scan has been found to be more consistently 
related to cognitive decline than the CT scan (de Leon, 
George, Ferris, Rosenbloom, Christman, Gentes, Reisberg, 
Kricheff & Wolf, 1983). In their study of 19 subjects 
(60-85), with 8 Alzheimer's patients and 11 normal 
subjects, de Leon et al. (1983) found all mean regional 
glucose use values to be significantly lower for the 
Alzheimer's patients. However, no differences were found 
with the regional CT scan data between the two groups. 
Interestingly though, they found a correlation between 
structural attenuation and mental status in the region of 
the temporal lobes for the CT scan. There was also a 
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correlation between thalamic CT attenuation and global 
reduction in brain metabolic activity. They suggest that 
the anatomic and metabolic changes may reflect impairment 
of thalamic functions although this is speculative at this 
point. Similar results were found by Duara, Grady, Haxby, 
Sundaram, Cutler, Heston, Moore, Schlageter, Larson and 
Rapoport (1986). They found no atrophy with the CT scan 
but reduced cerebral metabolism for 21 patients with a 
clinical diagnosis of Alzheimer's Disease. 
De Leon et al. (1983) found that they were able to 
correctly classify the Alzheimer's patients with accuracy 
greater that 80% utilizing the reduced glucose metabolic 
rate noted for the PET scan. They found consistent 
correlations between measures of glucose utilization and 
degree of cognitive impairment. 
Kuhl, Metter, Riege and Hawkins (1985) found that 2-
deoxy-2-fluror-D-glucose (FDG) scan is a sensitive 
indicator of local brain dysfunction in Multi-infarct 
dementia (MID). In MID, multiple lesions from focal 
ischemia caused an abnormal cerebral metabolic pattern. 
FDG scans revealed scattered metabolic defects in cortex, 
caudate, thalamus, white matter and cerebellum. 
Patients with Huntington's disease were found (Kuhl et 
al, 1985) to have markedly depressed glucose utilization 
(20%) in the.caudate and putamen regardless of duration of 
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the disease or the presence or absence of caudate atrophy. 
They suggest that decreased metabolism appears to be a 
"process that occurs prior to bulk loss of striatal 
tissue" (p. 421). 
In Alzheimer's type dementia, the FDG PET scan 
revealed (Kuhl et al., 1985) abnormal metabolic patterns 
which reflected neuronal degeneration most severe in the 
cortex. The average decrease in zonal metabolism was 47% 
in parietal and dorsolateral occipital cortex, and 28% in 
caudate and thalamus. Friedland, Budinger, Koss and Ober 
(1985) found a glucose metabolic decrease of 27% in the 
temporal-parietal cortex of an Alzheimer group. Chase, 
Fedio, Foster, Brooks, Di Chiro and Mansi (1984) found a 
significant positive correlation between cortical glucose 
use measured by the PET and the Full Scale IQ, Verbal IQ 
and Performance IQ scores on the Wechsler Adult 
Intelligence Scale in both normal and demented patients. 
The VIQ correlated more closely with cortical metabolism 
in the left cerebral hemisphere while PIQ correlated with 
cerebral metabolism of the right hemisphere. 
Greater impairment in cortical glucose metabolism was 
found in another study (Koss, Friedland, Ober & Jagust, 
1985) specifically for the right hemisphere in patients 
with early Alzheimer's disease. They studied 18 patients 
who met the DSM-III criteria for primary degenerative 
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dementia finding that the decline in metabolism was 
related to age of disease onset. Thus they suggest once 
again that Alzheimer's Dementia has two distinct 
populations. From their research they define a unique 
subset of patients under 65 years with a decrease in right 
hemisphere metabolic activity. 
Foster, Chase, Mansi, Brooks, Fedio, Patronas and Di 
Chiro (1984) found a 10-49% decrease in glucose 
utilization within the Alzheimer's group when compared 
with the control group. They observed that the posterior 
parieto-temporal areas were the most affected, whereas the 
frontal cortex and sensorimotor cortex were least 
affected. They postulated that as the disease progressed 
the frontal lobe would also become subject to 
deterioration. These finding support those of Friedland, 
Budinger, Ganz, Yano, Mathis, Koss, Ober, Heusmann and 
Derenzo (1983) who also found cortical degeneration to be 
most marked in the posterior temporal and parietal regions 
in Alzheimer's patients. 
Frackowiak, Pozzilli, Legg, DuBoulay, Marshall, Lenzi 
and Jones (1981) found a decline in cerebral blood 
flow and cerebral oxygen utilization which was correlated 
with severity of dementia. They found the parietal area 
to be most affected with a 29-33% fall in cerebral blood 
flow. There was a similar decline in the temporal area 
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also. Bilateral metabolism decrease was found (Friedland, 
Budinger, Brant-Zawadzki & Jagust, 1984) in temporal-
parietal cortex, and more markedly in the right 
hemisphere in their study of two Alzheimer's patients. 
PET, P300 and Dementia 
Given the new technological advances of the PET scan 
and the P300 latency measures, this study will investigate 
the relationship between these two techniques in 
individuals considered to be early, mild cases of 
Alzheimer's type dementia. Based upon past research, the 
use of both P300 latency and PET scan measures could 
assist greatly in the diagnosis of Alzheimer's Disease, 
perhaps even in its very early stages. One would expect 
to find decrease metabolism in the parietal, temporal and 
parahippocampal areas as well as a prolonged P300 latency. 
In combination, these two methods could greatly reduce the 
incidence of misdiagnosis. Furthermore in studying the 
relationship between the PET Scan and P300 latency, more 
understanding of the possible neural systems influencing 
the P300 may be gained. It is possible that the integrity 
of the parietal, temporal and parahippocampal systems is 
necessary in order to invoke a age-normal P300 latency. 
Thus as these system begin to decrease in their rate of 
glucose metabolism, the processes necessary for a normal 
P300 become less efficient. Perhaps fewer resources are 
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available for the encoding and processing of information, 
resulting in a prolonged P300 latency. Thus, a better 
understanding of the relationship between P300 and PET may 
enlighten us regarding the false negative that occur with 
the use of the P300 in diagnosis dementia. It is possible 
that, as long as the parietal and temporal systems are 
fairly well intact, the stimulus evaluation time is not 
decreased and normal P300 latency is seen even though the 
person may have signs of a dementing illness. Thus, it is 
hypothesized that: (a) the P300 latency is a reflection 
of brain integrity which will be manifest in PET indices 
of metabolic rate. (b) P300 latency will reflect cortical 
versus subcortical metabolic rate. (c) P300 latency will 
be specifically longer in those patients with reduced 
parietal and/or temporal metabolic rate. 
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signed letter of submission of my article to an 
appropriate journal be waived. Due to my involvement in a 
collaborative research grant, I must have any article 
approved and edited by several other members of the 
project including Dr. David Kuhl of the University of 
Michigan and Dr. Walter Reige of UCLA. At this time, Dr. 
Kuhl has not given his permission for any publication 
submissions. There are two articles in process at this 
time and will be submitted as soon as possible. 
Sincerely, 
~ // f . t'-1/ L 1-.. ~ " /~;z; kk x.._./j!<-"1- t7 1 /tZ-L ti_7c;:_£f:_r J 
Glena Lynne Needham Schubarth 
a2~pLe~ 
Warren S. Brown, Ph.D. 
Chair 
&:?-/ ~U~-t?__ 
Richard Gorsuch, Ph.D. 
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Appendix B 
Table 2 
Correlations of PET and P300 Latency Measures for PAD 
Group Only 
P300 Z-score P300 Raw Score 
-----------------------------------------------------
Global -0.2093 
-0.2194 
p = 0.125 p = 0.114 
Parietal/ 
Cerebellum -0.2569 -0.1778 
p = 0.078 p = 0.165 
Temporal/ 
Cerebellum -0.2640 -0.2350 
p = 0.072 p = 0.098 
Parahip/ 
Cerebellum -0.1863 -0.2271 
p = 0.154 p = 0.106 
Frontal/ 
Cerebellum -0.4193 -0.3771 
* 
p = 0.008 p = 0.017 
CaudThal/ 
Cerebellum -0.0230 -0.0518 
p = 0.450 p = 0.389 
Frontal/ 
Parietal -0.1237 -0.1913 
p = 0.250 p = 0.147 
Right Par/ 
Left Par 0.2071 0.2077 
p = 0.128 p = 0.127 
* p < 0.0012 
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Table 3 
Correlations of PET and P300 Latency Measures for Control 
Group Only 
Global 
Parietal/ 
Cerebellum 
Temporal/ 
Cerebellum 
Parahip/ 
Cerebellum 
Frontal/ 
Cerebellum 
CaudThal/ 
Cerebellum 
Frontal/ 
Parietal 
Right Par/ 
Left Par 
* 
p < 0.0012 
P300 Z-score 
-0.3762 
p = 0.068 
-0.0811 
p = 0.378 
0.3797 
p = 0.066 
0.2366 
p = 0.180 
0.0526 
p = 0.421 
0.2330 
p = 0.184 
0.3055 
p = 0.117 
0.3257 
p = 0.101 
P300 Raw Score 
-0.4844 
p = 0.024 
0.0748 
p = 0.388 
0.3144 
p = 0.110 
0.2874 
p = 0.132 
0.1885 
p = 0.234 
0.1693 
p = 0.258 
0.2792 
p = 0.139 
0.3849 
p = 0.064 
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Table 4 
Corr~lations for PET and P300 Latency Measures for PAD and 
Control Groups Combined 
P300 Z-score P300 Raw Score 
-----------------------------------------------------
Global -0.2112 -0.2232 
p = 0.073 p = 0.062 
Parietal/ 
Cerebellum -0.5336 -0.4962 
* * p = 0.001 p = 0.001 
Temporal/ 
Cerebellum -0.3915 -0.3946 
* * p = 0.003 p = 0.003 
Parahip/ 
Cerebellum -0.3803 -0.4068 
* * p = 0.004 p = 0.002 
Frontal/ 
Cerebellum -0.4662 -0.4330 
* * p = 0.001 p = 0.001 
CaudThal/ 
Cerebellum -0.0078 -0.0351 
p = 0.479 p = 0.405 
Frontal/ 
Parietal 0.2500 0.2219 
p = 0.042 p = 0.063 
Right Par/ 
Left Par 0.2604 0.2623 
p = 0.035 p = 0.034 
', ' 
* 
p < 0.0012 
Figure Captions 
Figure 5: 
This scatterplot displays the regression line 
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for the correlation of P300 Z-scores and the 
parietal/cerebellum ratio. "A" represents each patient 
data point. "C" represents each control data point. 
Figure 6: 
This scatterplot shows the correlation of the P300 z-
scores and the temporal/cerebellum correlation. "A" 
indicates patient. 
Figure 7: 
"C" indicates control. 
This figure displays the P300 z-score and 
frontal/cerebellum ratio correlation and regression line. 
"A" represents the patient, and "C" represents the 
control. 
Figure 8: 
This scatterplot shows the correlation between P300 z-
scores and the parahippocampus/cerebellum ratio. The "A" 
indicates a patient data point, the "C" a control. 
Figure 9: 
This figure shows the P300 z-score and global measure 
correlation and regression line. 
data point, "C" a control. 
"A" indicates a patient 
Figure 10: 
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This shows the correlation for P300 z-scores and the 
frontal/parietal ratio. Patients are indicated by "A", 
controls by "C". 
Figure 11: 
The scatterplot shows the P300 z-score and right/left 
parietal ratio correlation with patients desinatedby "A" 
and controls by "C". 
Figure 12: 
Thei figure shows the correlation between the P300 z-
scores and the caudate thalamus/cerebellum ratio. 
Patients are repsented with an "A", controls with a "C". 
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Descr1pt1ve stat1st1cs 
CODE OR N (%) OR STAND. DEVIATION 
VARIABLE OBS. RANGE t-EAN SAMPLE/POP. EST. 
GROUP 49 ( 100%) 
DEt-ENT 1 32 (65.3) 
NORMAL 2 17 (34.7) 
AGE 51- 76 65.939 6.457 6.524 
P300LAT 290- 575 395.918 67.949 68.653 
P3SD -1.66- 8.22 2.139 2.335 2.359 
SEVERITY 49 (100%) 
CDRO 0 17 (34.7) 
CDRS 5 18 (36. 7) 
CDRl 1 14 (28.6) 
MMS 20- 30 25.939 3.067 3.098 
Total N = 49 
Correlation Coeff1c1ents 
V ar1 abl es 
2. AGE 
3. P300LAT 
4. P3SD 
6. MMS 
N = 49 
2. 3. 4. 6. 
1.00 
• 21 1.00 
-.03 • 95 1.00 
-.31 -.65 -.59 1.00 
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All Subjects by Diagnosis 
ANALYSIS OF VARIANCE 
SUMMARY TABLE FOR AGE 
PALLAI-
EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DF1 F RATIO p 
116 
GROUP R = .23 .OS 1 2.52 .1 
Notes: N = 49 
GROUP 
DEMENT 
NORMAL 
df2 = 47 
AGE MEANS 
MEAN 
67.0000 
63.9412 
N 
32 
17 
AGE Mean = 65.9 Standard deviation = 6.5 
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ANALYSIS OF VARIANCE 
SUMMARY TABLE FOR AGE 
PALLAI-
EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DF1 F RATIO p 
117 
---------------------------------------------
SEVERITY R = .28 .08 2 1.88 .2 
df2 = 46 
Notes: N = 49 
Effect size 1s multiple correlation/eta (R). 
AGE MEANS 
SEVERITY 
CDRO 
CDRS 
CDR1 
MEAN 
63.9412 
65.8889 
68.4286 
N 
17 
18 
14 
AGE Mean = 65.9 Standard deviation = 6.5 
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F TEST OF CORRELATION 
SUMMARY TABLE FOR AGE 
PALL AI-
EFFECT BARTLETT CHI SQ. OR 
118 
VARIABLE SIZE V DF1 F RATIO p 
MMS r = -.31 .10 1 5.01 .03 
df2 = 47 
Notes: N = 49 
Effect size is product-moment correlation (r). 
Tests are two-tailed. For a one-ta1led test, divide 
the p of any variable w1th df = 1 by two IF the results 
are in the predicted d1rect1on. 
ESTIMATING SCORES FOR AGE FROM MMS 
Samples of 
MMS 
20.0 
23.0 
25.0 
28.0 
30.0 
Estimated 
AGE 
69.820 
67.860 
66.552 
64.592 
63.284 
SE of estimate = 6.1378 
Linear equation= 82.89203 + (-.65359 ) * MMS 
AGE Mean = 65.9 Standard deviation = 6.5 
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All Subjects by CDR 
ANALYSIS OF VARIANCE 
SUMMARY TABLE FOR P3SD 
PALLAI-
EFFECT BARTLETT CHI SQ. OR 
119 
VARIABLE SIZE V DF1 F RATIO p 
---------------------------------------------
SEVERITY R = .64 .41 2 15.98 <.0005 
df2 = 46 
Notes: N = 49 
Effect size 1s multiple correlation/eta (R). 
P3SD MEANS 
SEVERITY MEAN N 
-----------------------CDRO 
CDRS 
CDR1 
.0929 
3.1056 
3.3800 
17 
18 
14 
P3SD Mean = 2.1 Standard deviation = 2.3 
All Subjects by CDR 
ANALYSIS OF VARIANCE 
SUMMARY TABLE FOR P300LAT 
PALLAI-
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EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DF1 F RATIO p 
SEVERITY R = .66 .44 2 17.98 <.0005 
df2 = 46 
Notes: N = 49 
Effect size is multiple correlation/eta (R). 
P300LAT MEANS 
SEVERITY MEAN N 
-----------------------CDRO 
CDRS 
CDR1 
334.7059 
421.9445 
436.7857 
17 
18 
14 
P300LAT Mean= 395.9 Standard deviation = 67.9 
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All Subjects by CDR 
ANALYSIS OF VARIANCE 
SUMMARY TABLE FOR MMS 
PALL AI-
EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DF1 F RATIO p 
121 
---------------------------------------------
SEVERITY R = .92 .84 2 122.24 <.0005 
df2 = 46 
Notes: N = 49 
Effect size is multiple correlation/eta (R). 
MMS MEANS 
SEVERITY 
CDRO 
CDR5 
CDR1 
MEAN 
29.5882 
25.0000 
22.7143 
N 
17 
18 
14 
MMS Mean = 25.9 Standard deviation = 3.1 
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All Subjects by P300 Z-Score 
F TEST OF CORRELATION 
SUMMARY TABLE FOR f.f.1S 
PALL AI-
EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DF1 F RATIO p 
122 
---------------------------------------------
P3SD r = -.59 .35 1 25.25 <.0005 
df2 = 47 
Notes: N = 49 
Effect size is product-moment correlation (r). 
Tests are two-tailed. For a one-tailed test, divide 
the p of any variable with df = 1 by two IF the results 
are 1n the predicted direction. 
ESTIMATING SCORES FOR MMS FROM P3SD 
Samples of 
P3SD 
-2.0 
.o 
2.0 
5.0 
7.0 
Estimated 
MMS 
29.152 
27.599 
26.047 
23.718 
22.165 
SE of estimate = 2.4734 
linear equation= 27.59919 + (-.77634 ) * P3SD 
MMS Mean = 25.9 Standard deviation = 3.1 
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All Subjects by P300 Raw Latency Score 
F TEST OF CORRELATION 
SUMMARY TABLE FOR MMS 
PALLAI-
EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DF1 F RATIO p 
123 
---------------------------------------------
P300LAT r = -.65 .42 1 33.77 <.0005 
df2 = 47 
Notesz N = 49 
Effect size is product-moment correlation (r). 
Tests are two-tailed. For a one-tailed test, divide 
the p of any variable with df = 1 by two IF the results 
are in the predicted direction. 
ESTIMATING SCORES FOR M~S FROM P300LAT 
Samples of Estimated 
290.0 
351.0 
411.0 
472.0 
532.0 
P300LAT Mt~S 
29.030 
27.250 
25.499 
23.718 
21.967 
SE of estimate = 2.3393 
Linear equation= 37.49298 + (-2.9180000E-02 ) * P300LAT 
MMS Mean = 25.9 Standard deviation = 3.1 
Appendix 
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ANALYSIS OF VARIANCE 
SUMMARY TABLE FOR P3SD 
PALLAI-
EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DF1 F RATIO p 
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---------------------------------------------
SEVERITY R = .70 .48 1 30.90 <.0005 
df2 = 33 
Notes: N = 35 
Effect size is multiple correlation/eta (R). 
Tests are two-tailed. For a one-tailed test, divide the p 
of any variable with df = 1 by two IF the results are 1n 
the predicted direction. 
P3SD MEANS 
SEVERITY 
CDRO 
CDRS 
MEAN 
.0929 
3.1056 
N 
17 
18 
P3SD Mean = 1.6 Standard deviation = 2.2 
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ANALYSIS OF VARIANCE 
SUMMARY TABLE FOR P300LAT 
PALLAI-
EFFECT BARTLETT CHI SO. OR 
VARIABLE SIZE V DF1 F RATIO p 
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---------------------------------------------
SEVERITY R = .71 .50 1 33.66 <.0005 
df2 = 33 
Notes: N = 35 
Effect size is multiple correlation/eta (R). 
Tests are two-tailed. For a one-tailed test, divide the p 
of any variable with df = 1 by two IF the results are in 
the predicted direction. 
P300LAT MEANS 
SEVERITY MEAN N 
-----------------------CDRO 
CDRS 
334.7059 
421.9445 
17 
18 
P300LAT Mean = 379.6 Standard deviation = 61.4 
i 
I,, 
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ANALYSIS OF VARIANCE 
SUMMARY TABLE FOR MMS 
PALLAI-
EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DFl F RATIO p 
126 
-----------------~---------------------------
SEVERITY R = .89 .80 1 131.70 <.0005 
df2 = 33 
Notes: N = 35 
Effect size is multiple correlation/eta (R). 
Tests are two-tailed. For a one-tailed test, divide the p 
of any variable with df = 1 by two IF the results are in 
the predicted direction. 
MMS ~ANS 
SEVERITY MEAN N 
-----------------------CDRO 29.5882 17 
CDRS 25.0000 18 
MMS Mean = 27.2 Standard deviation = 2.6 
, 
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ANALYSIS OF VARIANCE 
SUMMARY TABLE FOR P3SD 
PALLAI-
EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DF1 F RATIO p 
127 
---------------------------------------------
SEVERITY R = .06 .00 1 .12 n. s. 
df2 = 30 
Notes: N = 32 
Effect size is multiple correlation/eta (R). 
Tests are two-tailed. For a one-tailed test, 
divide the p of any variable with df = 1 by two IF the 
results are in the predicted direction. 
P3SD MEANS 
SEVERITY 
CDRS 
CDR1 
MEAN 
3.1056 
3.3800 
N 
18 
14 
P3SD Mean = 3.2 Standard dev1at1on = 2.1 
PAD Subjects by CDR 
ANALYSIS OF VARIANCE 
SUMMARY TABLE FOR P300LAT 
PALL AI-
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EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DF1 F RATIO p 
SEVERITY R = .12 .01 1 .44 n.s. 
df2 = 30 
Notes: N = 32 
Effect s1ze 1s multiple correlation/eta (R). 
Tests are two-tailed. For a one-tailed test, d1v1de 
the p of any variable with df = 1 by two IF the results 
are in the predicted direction. 
P300LAT MEANS 
SEVERITY 
CDRS 
CDR1 
MEAN 
421.9444 
436.7857 
N 
18 
14 
P300LAT Mean = 428.4 Standard deviation = 61.3 
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F TEST OF CORRELATION 
SUMMARY TABLE FOR AGE 
PALLAI-
EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DF1 F RATIO p 
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---------------------------------------------
MMS r = -.31 .10 1 3.25 .08 
df2 = 30 
Notes: N = 32 
Effect size is product-moment correlation (r). 
Tests are two-tailed. For a one-ta1led test, divide 
the p of any variable with df = 1 by two IF the results 
are 1n the predicted direction. 
ESTIMATING SCORES FOR AGE FROM MMS 
Samples of 
MMS 
Estimated 
AGE 
----------------------20.0 
22.0 
24.0 
26.0 
28.0 
70.889 
68.944 
67.000 
65.056 
63.111 
SE of estimate = 5.4254 
Linear equation= 90.33333 + (-.97222 > * MMS 
AGE Mean= 67 Standard deviation= 5.7 
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ANALYSIS OF VARIANCE 
SUMMARY TABLE FOR MMS 
PALLAI-
EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DF1 F RATIO p 
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---------------------------------------------
SEVERITY R = .62 .38 1 18.46 <.0005 
df2 = 30 
Notes: N = 32 
Effect size is multiple correlation/eta (R). 
Tests are two-tailed. For a one-tailed test, divide the p 
of any variable w1th df = 1 by two IF the results are in 
the predicted direction. 
MMS MEANS 
SEVERITY 
CDRS 
CDR1 
MEAN 
25.0000 
22.7143 
N 
18 
14 
MMS Mean = 24 Standard dev1at1on = 1.8 
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F TEST OF CORRELATION 
SUMMARY TABLE FOR MMS 
PALLAI-
EFFECT BARTLETT CHI SQ. OR 
VARIABLE SIZE V DF1 F RATIO p 
131 
P3SD r = -.11 .01 1 .37 n. s. 
df2 = 30 
Notes: N = 32 
Effect size is product-moment correlation <r>. 
Tests are two-tailed. For a one-tailed test, divide the p 
of any variable with df = 1 by two IF the results are 1n 
the predicted direction. 
ESTIMATING SCORES FOR MMS FROM P3SD 
Samples of 
P3SD 
.o 
2.0 
4.0 
5.0 
7.0 
Estimated 
MMS 
24.308 
24.117 
23.926 
23.831 
23.640 
SE of estimate = 1.8258 
Linear equation= 24.30806 + (-9.5500000E-02 > * P3SD 
MMS Mean = 24 Standard dev1at1on = 1.8 
Stage 0: 
Stage 1: 
Stage II: 
Stage III: 
Appendix C 
* 
Flow Chart of Evaluation Process 
Recruitment 
Initial Assessment 
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(Completed by the Public Health Nurse or 
Clinic Therapist) 
Primary Dementia Evaluation 
Social work evaluation 
Psychiatric Interview 
mini-mental state exam 
portion of Hachinski 
Hamilton Depression Scale 
Clinical Neuropsychological Evaluation 
Neurolinguistic Evaluation 
Blood, Urine, Lab tests 
CT scan 
EEG 
Referral to Project 
Neurological Evaluation 
complete Hachinski 
Review of data 
Decision to include in study 
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Stage IV: Study Group 
* 
PET FDG Scan 
Multivariate Memory Test 
P300 Latency Recordings 
Kuhl, D.E. (1983), Emission computed tomography of local 
cerebral functions, Unpublished grant proposal, 
University of California, Los Angeles. 
Appendix D 
Neuropsychological Battery 
General Intelligence 
Wechsler Adult Intelligence Scale 
Memory 
Benton Visual Retention Test (Benton, 1974) 
Rey Auditory Verbal Learning Test (Rey, 1964) 
Attention and Concentration 
Number Cancellation Protocol (Lezak, 1983) 
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Smith Symbol-Digit Modalities Test (Smith, 1973) 
Trail Making Test A and B 
Test of Abstract Reasoning 
Raven's colored Progressive Matrices 
Test of Visuoconceptual Abilities 
Hooper Visual Organization Test (Hooper, 1958) 
Appendix E 
Clinical Dementia Rating Scale 
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The Clinical Dementia Rating (CDR) scale utilized 
information gathered through interviews to determine what 
stage of dementia the patient has reached. The stages 
include: questionable~ moderate or severe. There are six 
categories of functioning that are assessed which include: 
memory, orientation, judgment/problem solving, community 
affairs, home/hobbies and personal care (see chart). The 
numerical ratings are as follows: A score of 0 = healthy 
functioning, no difficulties in any category; 0.5 =mild 
impairment~ 1.0 =moderate memory loss, mild dementia~ 2.0 
= moderate dementia, severe memory loss and disorientation 
to time or 3.0 = severe dementia, severe memory loss, 
disorientation to person, and personal care minimal or 
non-existent. 
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A New Clinical Scale for the Staging of Dementia 
Memory 
Clinical dementia rating (CDR) 
Healthy 
CDR 0 
No memory 
loss or 
slight 
inconstant 
forgetful-
ness 
Questionable dementia 
CDR 0.5 
Mild consistent 
forgetfulness; 
partial recollection 
of events; 'benign' 
forgetfulness 
Orientation 
Fully 
oriented 
Fully 
oriented 
Judgment/Problem Solving 
Solves Only doubtful 
everyday impairment in 
problems solving problems, 
well; similarities, 
judgment differences 
good in 
relation to 
past performance 
Mild dementia 
CDR 1. 0 
Moderate 
memory loss 
more marked 
for recent 
events; 
defect 
interferes 
with every-
day 
activities 
SomE:! 
difficu,l ty 
with time 
relationships 
oriented for 
place and 
person at 
exam but may 
have geo-· 
graphic 
disorienta-
Moderate 
difficulty in 
handling 
complex 
problems; 
social 
judgment 
usually 
maintained 
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CDR 0 CDR 0.5 CDR 1. 0 
--------------------------------------------------------
Community affairs 
Independent 
function at 
usual level 
in job, 
shopping, 
business, 
and financial 
affairs, 
volunteer 
and social 
groups 
Home and Hobbies 
Only doubtful or mild 
impairment, if any in 
these activities 
Unable to 
function 
independently 
at these 
activities 
though may 
still be 
engaged in 
some; may 
still appear 
normal to 
casual 
inspection 
Life at Life at home, hobbies Mild but 
home, intellectual interests definite 
intellectual well maintained or impairment 
interests only slightly of function 
well impaired at home; 
maintained more 
Personal care 
Fully 
capable 
of self 
care 
Fully capable of 
self care 
difficult 
chores 
abandoned; 
more compli-
cated hobbies 
and interests 
abandoned 
Needs 
occasional 
prompting 
Memory 
Orientation 
Moderate dementia 
CDR 2.0 
Severe memory loss; 
only highly learned 
material retained; 
new material 
rapidly lost 
Usually disoriented 
in time, often to 
place 
Judgment/problem solving 
Severely impaired in 
handling problems, 
similarities, 
differences; social 
judgment 
usually impaired 
Community affairs 
No pretense of 
independent function 
outside home 
Home and hobbies 
Personal care 
Only simple chores 
preserved; very 
restricted interests, 
poorly sustained 
Requires assistance 
in dressing, hygiene, 
keeping of personal 
effects 
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Severe dementia 
CDR 3.0 
Severe memory loss; 
only fragments 
remain 
Orientation to 
person only 
Unable to make 
judgments or 
solve problems 
No pretense of 
independent function 
outside home 
No significant 
function in home 
outside of own 
room 
Requires much help 
with personal care; 
often incontinent 
CDR Score 
---------------------
Instructions for CDR 
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Use all information and make the best judgment. 
Score each category as independently as possible. Mark in 
only one box, rating each according to subject's cognitive 
function. For determining the CDR, memory is considered 
the primary category; all others are secondary. If at 
least three secondary categories are given the same 
numerical score as memory, the CDR = memory. If three or 
more secondary categories are given a score greater or 
less than the memory score, CDR = score of majority of 
s~condary categories, unless three secondary categories 
are scored on one side of memory and two secondary 
categories are scored on the other side of memory. In 
this last circumstance, CDR = memory. 
When memory= 0.5, CDR= 1 if at least three of 
certain others (Orientation, Judgment, Community Affairs, 
Home and Hobbies) are scored 1.0 or greater (Personal care 
is not influential here). If Memory= 0.5, CDR cannot be 
0, CDR can only be 0.5 or 1.0. If memory = 1, CDR= 1 
unless there is slight impairment in two or more secondary 
categories, in which case CDR= 0.5. 
Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A., & 
Martin, R.L., (1982). A new clinical scale for the 
staging of dementia. British Journal of Psychiatry, 
140, 566-572. 
Appendix F 
Mini-Mental State 
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The Mini-Mental State Exam (MMS) was developed by 
Folstein, Folstein and McHugh (1975) as a formalized, 
normed mental status exam consisting of 30 questions. The 
subsections of the MMS include: orientation, memory, 
attention, expressive/receptive abilities and visuographic 
tasks (see protocol). The MMS is sensitive to changes in 
cognitive impairment. High scores (28-30) are indications 
of little or no impairment. Lower scores suggest moderate 
to severe impairment. An increase in the MMS score across 
time occurs in reversible dementia. 
Mini-Mental State 
by M.F. Folstein, 
S,E. Folstein, and 
P.R. McHugh 
I. Orientation 
Ask, "What is today's date?" 
Then ask specifically for 
parts omitted; e.g., "Can 
you also tell me what season 
it is?" 
Ask, "Can you tell me the 
name of this hospital?" 
"What floor are we on?" 
"What town (or city) are we 
in?" 
"What county are we in?" 
"What state are we in?" 
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Patient's Name 
----------------
Test Date 
----------------------
Testor Name 
--------------------
Score 1 = correct 
2 = incorrect 
Date (e.g. Jan. 21) .. 1 
Year ................. 2 
Month ................ 3 
Day (e.g. Monday) .... 4 
Season ............... 5 
Hospital ............. 6 
Floor ................ 7 
Town ................. 8 
County ............... 9 __ __ 
state ............... 1 0 
II. Registration 
Ask the subject if you may 
test his/her memory. Then 
say "ball," "flag," "tree" 
clearly and slowly, about one 
second for each. After you have 
said all 3, ask him/her to 
repeat them. This first 
repetition determines his/her 
score (0-3) but keep saying 
them until s/he can repeat all 
3, up to 6 trials. If s/he 
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"Ba 11 " •••••••••••••• 11 
"Flag" .............. 12 
"Tree" .............. 13 
Number of trials .... 14 
(number 14 not included in 
in score) 
does not eventually learn all 3, 
recall cannot be meaningfully tested. 
III. Attention and Calculation 
Ask the subject to begin with 
100 and count backwards by 7. 
Stop after 5 subtractions 
( 9 3, 8 6, 7 9, 7 2, 6 5) . Score 
the total number of correct 
answers. If the subject cannot 
or will not perform this task, 
ask him/her to spell the word 
"world" backwards. The score is 
"93" •............... 15 
'' 86 ,, ................ 16 
11 79 II o • • • • • • • o • • • • • • • 17 
II 72 II • • • • • o • • • • • • • • • • 18 
"65" ........•..••.•• 19 
the number of letters in correct order. 
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For example, dlrow = 5, dlorw = 3, 
Records how the subject spelled 
"world" backwards 
d 1 o r w 
IV. Recall 
Ask the subject to recall 
the 3 words you previously 
asked him/her to remember. 
Score 0-3. 
v. Language 
naming: Show the subject 
a wrist watch and ask him/her 
what it is. Repeat for 
pencil. 
repetition: Ask the 
subject to repeat, "No ifs, 
and, or buts." 
3-stage command: Give 
the subject a piece of 
plain blank paper and say, 
"Take the paper in your right 
Number of letters in 
correct order ...... 20 
(include either number 19 
or 20 in score) 
"Ball" ............. 21 
"Flag" ............. 22 
"Tree" ............. 23 
Watch ............... 24 
Penci 1 ............. 25 
Repetition ......... 26 __ __ 
Takes paper in 
in right hand ...... 27 
Folds paper in 
half ............ 28 
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hand, fold it in half and put 
it on the floor." 
Puts paper on 
floor ............ 29 
---------------------------------------------------------
reading: On a blank piece 
of paper print the sentence, 
"Close your eyes," in letters 
large enough for the subject to 
see clearly. Ask him/her to read 
it arid do what it says. Score 
correct only if s/he actually 
closes his/her eyes. 
writing: Give the subject a 
blank piece of paper and ask 
him/her to write a sentence. 
Closes eyes ........ 30 
It is to be written spontaneously. 
It must contain a subject and 
verb and be sensible. Correct 
grammar and punctuation are 
not necessary. Writes sentence .... 31 
copying: On a clean piece of 
paper, draw intersecting penta-
gons, each side about 1 inch, and 
ask subject to copy it exactly as 
it is. All 10 angles must be 
present and two must intersect to 
score 1 point. Tremor and 
rotation are ignored. 
e.g. 
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Draws pentagons .... 32 
Rate subject's level of consciousness 
(a) coma 
(b) stupor 
(c) drowsy 
(d) alert 33 
(number 33 not included 
in score) 
TOTAL CORRECT 
Appendix G 
Hachinski Ischemic Score 
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Hachinski et al. (1975) studied cerebral blood flow of 
24 patients in an attempt to differentiate demented 
patients fr?m non-demented patients. The variables 
measured included blood flow through fast-clearing tissue 
mainly gray matter (Ff); Blood flow through slow-clearing 
tissue, white matter (Fs); the portion of tissue clearing 
at the fast rate (Wf); flow measured from the slope of the 
first two minutes of the logarithmically displayed isotope 
clearance curve (F initial); and weighted mean flow (F). 
Their results indicated that patients fell into two groups 
with 10 patients scoring 7 and above on the Ischemic Scale 
and 14 patients scoring 4 and below. Patients with a 
score of 7 and above were classified as having multi-
infarct dementia. Those with a score of 4 and below were 
classified as having primary degenerative dementia. 
Clinical Features of Ischemic Scale 
Feature 
Sudden onset 
Stepwise deterioration 
Fluctuating course 
Nocturnal confusion 
Relative preservation 
Score 
2 
1 
2 
1 
of personality 1 
Depression 1 
Somatic complaints 1 
Emotional incontinence 1 
History of hypertension 1 
History of strokes 2 
Evidence of associated 
atherosclerosis 1 
Focal neurological 
symptoms 2 
Focal neurological signs 2 
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Hachinski, V.C., Iluff, L D., Phil M., Zilhka, E., Du 
Boulay, G. H., McAllister, V.L., Marshall, J., 
Russell, R.W.~., & Lyman, L (1975) Cerebral blood 
flow in dementia, Archives of Neurology, 32, 632-637 
Appendix II 
Epilogue 
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Following completion of this study, it became evident 
that multiple runs are very important to ensure obtaining 
the most clear P300 latency record possible. Making sure 
that at least two complete runs were obtained from each 
patient and control would be one improvement that could be 
made from the onset of the study. 
For future studies it would be interesting to study 
the P300 latency measures for each subsequent year in 
order to discover if there are any patterns that might be 
particular to Alzheimer's patients. It may also be 
informative to correlate these follow-up P300 latencies 
with corresponding PET scans. With this particular group 
of subjects, analyses of memory, neuropsychological and/or 
psycholinguistic data could also be completed and compared 
with the initial P300 latency measures. 
Furthermore, it would be advantageous to obtain PET 
scans and P300 latency measurements on patients with 
dementia secondary to Huntington's Disease, and compare 
the findings with the Alzheimer's patients in order to 
note similarities and differ~nces between the two groups. 
It is known that both groups have prolonged P300 
latencies, but different patterns of cerebral 
degeneration. 
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